EP0673246A1 - Use of alkylthiopyridines for controlling helicobacter bacteria - Google Patents
Use of alkylthiopyridines for controlling helicobacter bacteriaInfo
- Publication number
- EP0673246A1 EP0673246A1 EP94902761A EP94902761A EP0673246A1 EP 0673246 A1 EP0673246 A1 EP 0673246A1 EP 94902761 A EP94902761 A EP 94902761A EP 94902761 A EP94902761 A EP 94902761A EP 0673246 A1 EP0673246 A1 EP 0673246A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- hydrogen
- alkyl
- alkoxy
- benzimidazole
- thio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000589989 Helicobacter Species 0.000 title claims abstract description 27
- 150000001875 compounds Chemical class 0.000 claims abstract description 64
- -1 1-4C-alkyl Chemical group 0.000 claims description 385
- 229910052739 hydrogen Inorganic materials 0.000 claims description 167
- 239000001257 hydrogen Substances 0.000 claims description 167
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 133
- 150000002431 hydrogen Chemical group 0.000 claims description 129
- 229910052736 halogen Inorganic materials 0.000 claims description 73
- 150000002367 halogens Chemical group 0.000 claims description 73
- 150000003839 salts Chemical class 0.000 claims description 53
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 51
- 125000003118 aryl group Chemical group 0.000 claims description 44
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 36
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 27
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 24
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 23
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 23
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 15
- 125000005002 aryl methyl group Chemical group 0.000 claims description 14
- 125000004789 chlorodifluoromethoxy group Chemical group ClC(O*)(F)F 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 176
- 125000001241 2-phenylethylthio group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])S* 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000005022 packaging material Substances 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001556 benzimidazoles Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000027119 gastric acid secretion Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- YGTUPRIZNBMOFV-UHFFFAOYSA-N 2-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(=O)C1=CC=C(O)C=C1 YGTUPRIZNBMOFV-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- QIJAOIBSOZSHMF-UHFFFAOYSA-N 2-[(3-methoxy-4-pentylsulfanylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CCCCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1OC QIJAOIBSOZSHMF-UHFFFAOYSA-N 0.000 description 1
- OLCYYAVKLJZWAJ-UHFFFAOYSA-N 2-[(3-methoxy-4-propan-2-ylsulfanylpyridin-2-yl)methylsulfanyl]-1H-benzimidazole Chemical compound C(C)(C)SC1=C(C(=NC=C1)CSC1=NC2=C(N1)C=CC=C2)OC OLCYYAVKLJZWAJ-UHFFFAOYSA-N 0.000 description 1
- USLGSNYWIZWKOX-UHFFFAOYSA-N 2-[(3-methoxy-4-propylsulfanylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1OC USLGSNYWIZWKOX-UHFFFAOYSA-N 0.000 description 1
- KIQHFBCVYLLKRE-UHFFFAOYSA-N 2-[(3-methyl-4-pentylsulfanylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CCCCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1C KIQHFBCVYLLKRE-UHFFFAOYSA-N 0.000 description 1
- QWUZNNSTYYRCAG-UHFFFAOYSA-N 2-[(3-methyl-4-propan-2-ylsulfanylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CC(C)SC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1C QWUZNNSTYYRCAG-UHFFFAOYSA-N 0.000 description 1
- AOGLTQPCEFHXLS-UHFFFAOYSA-N 2-[(3-methyl-4-propylsulfanylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1C AOGLTQPCEFHXLS-UHFFFAOYSA-N 0.000 description 1
- YYVCULAXWVEOAG-UHFFFAOYSA-N 2-[(4-benzylsulfanyl-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CC1=CN=C(CSC=2NC3=CC=CC=C3N=2)C(C)=C1SCC1=CC=CC=C1 YYVCULAXWVEOAG-UHFFFAOYSA-N 0.000 description 1
- KVKOVEDQMXBZQR-UHFFFAOYSA-N 2-[(4-benzylsulfanyl-3,5-dimethylpyridin-2-yl)methylsulfanyl]-6-(difluoromethoxy)-1H-benzimidazole Chemical compound CC1=CN=C(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)C(C)=C1SCC1=CC=CC=C1 KVKOVEDQMXBZQR-UHFFFAOYSA-N 0.000 description 1
- CWFNNSPHVXCZHR-UHFFFAOYSA-N 2-[(4-benzylsulfanyl-3,5-dimethylpyridin-2-yl)methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(C=1C)=NC=C(C)C=1SCC1=CC=CC=C1 CWFNNSPHVXCZHR-UHFFFAOYSA-N 0.000 description 1
- XICYOIFQOXAPNL-UHFFFAOYSA-N 2-[(4-benzylsulfanyl-3-methoxypyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound COC1=C(CSC=2NC3=CC=CC=C3N=2)N=CC=C1SCC1=CC=CC=C1 XICYOIFQOXAPNL-UHFFFAOYSA-N 0.000 description 1
- UDUVMWGODOJCPZ-UHFFFAOYSA-N 2-[(4-benzylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-6-(2,2,2-trifluoroethoxy)-1h-benzimidazole Chemical compound CC1=C(CSC=2NC3=CC(OCC(F)(F)F)=CC=C3N=2)N=CC=C1SCC1=CC=CC=C1 UDUVMWGODOJCPZ-UHFFFAOYSA-N 0.000 description 1
- KVBLJYGHKRXLSS-UHFFFAOYSA-N 2-[(4-benzylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-6-(difluoromethoxy)-1h-benzimidazole Chemical compound CC1=C(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)N=CC=C1SCC1=CC=CC=C1 KVBLJYGHKRXLSS-UHFFFAOYSA-N 0.000 description 1
- UNLLYTWWKOGAHE-UHFFFAOYSA-N 2-[(4-benzylsulfanylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound C=1C=NC(CSC=2NC3=CC=CC=C3N=2)=CC=1SCC1=CC=CC=C1 UNLLYTWWKOGAHE-UHFFFAOYSA-N 0.000 description 1
- LHJGRRQOWMOJPZ-UHFFFAOYSA-N 2-[(4-benzylsulfanylpyridin-2-yl)methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(N=CC=1)=CC=1SCC1=CC=CC=C1 LHJGRRQOWMOJPZ-UHFFFAOYSA-N 0.000 description 1
- JOMHKJSVNVVPPJ-UHFFFAOYSA-N 2-[(4-butylsulfanyl-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CCCCSC1=C(C)C=NC(CSC=2NC3=CC=CC=C3N=2)=C1C JOMHKJSVNVVPPJ-UHFFFAOYSA-N 0.000 description 1
- ZRDYSCJEIFBFKJ-UHFFFAOYSA-N 2-[(4-butylsulfanyl-3-methoxypyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CCCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1OC ZRDYSCJEIFBFKJ-UHFFFAOYSA-N 0.000 description 1
- VZRJBMGVISIYDC-UHFFFAOYSA-N 2-[(4-butylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CCCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1C VZRJBMGVISIYDC-UHFFFAOYSA-N 0.000 description 1
- XJIAACBESKOZPE-UHFFFAOYSA-N 2-[(4-butylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-6-(2,2,2-trifluoroethoxy)-1h-benzimidazole Chemical compound CCCCSC1=CC=NC(CSC=2NC3=CC(OCC(F)(F)F)=CC=C3N=2)=C1C XJIAACBESKOZPE-UHFFFAOYSA-N 0.000 description 1
- LHFMBGROAOZAPF-UHFFFAOYSA-N 2-[(4-butylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-6-(difluoromethoxy)-1h-benzimidazole Chemical compound CCCCSC1=CC=NC(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)=C1C LHFMBGROAOZAPF-UHFFFAOYSA-N 0.000 description 1
- NHZGQZPTVSBQDZ-UHFFFAOYSA-N 2-[(4-butylsulfanylpyridin-2-yl)methylsulfanyl]-1h-benzimidazole Chemical compound CCCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1 NHZGQZPTVSBQDZ-UHFFFAOYSA-N 0.000 description 1
- HWIAARDLTGICOQ-UHFFFAOYSA-N 2-[(4-butylsulfanylpyridin-2-yl)methylsulfanyl]-6-(difluoromethoxy)-1H-benzimidazole Chemical compound C(CCC)SC1=CC(=NC=C1)CSC1=NC2=C(N1)C=CC(=C2)OC(F)F HWIAARDLTGICOQ-UHFFFAOYSA-N 0.000 description 1
- ZHLGPECURCCRQS-UHFFFAOYSA-N 2-[(4-cyclohexylsulfanyl-3-methoxypyridin-2-yl)methylsulfanyl]-1H-benzimidazole Chemical compound C1(CCCCC1)SC1=C(C(=NC=C1)CSC1=NC2=C(N1)C=CC=C2)OC ZHLGPECURCCRQS-UHFFFAOYSA-N 0.000 description 1
- JDEQYWDSSAOFRM-UHFFFAOYSA-N 2-[(4-cyclohexylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-1H-benzimidazole Chemical compound C1(CCCCC1)SC1=C(C(=NC=C1)CSC1=NC2=C(N1)C=CC=C2)C JDEQYWDSSAOFRM-UHFFFAOYSA-N 0.000 description 1
- OJUJJRVAVRPBDH-UHFFFAOYSA-N 2-[(4-cyclopentylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-1H-benzimidazole Chemical compound C1(CCCC1)SC1=C(C(=NC=C1)CSC1=NC2=C(N1)C=CC=C2)C OJUJJRVAVRPBDH-UHFFFAOYSA-N 0.000 description 1
- MPRHDSURSPNCNF-UHFFFAOYSA-N 2-[(4-cyclopropylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-1H-benzimidazole Chemical compound C1(CC1)SC1=C(C(=NC=C1)CSC1=NC2=C(N1)C=CC=C2)C MPRHDSURSPNCNF-UHFFFAOYSA-N 0.000 description 1
- JREUVAJQXMDGHO-UHFFFAOYSA-N 2-[[3,5-dimethyl-4-[(4-methylphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(C)=CC=C1CSC1=C(C)C=NC(CSC=2NC3=CC=CC=C3N=2)=C1C JREUVAJQXMDGHO-UHFFFAOYSA-N 0.000 description 1
- WKKNMRQHYCXDMP-UHFFFAOYSA-N 2-[[3-methoxy-4-[2-(4-methylphenyl)ethylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound COC1=C(CSC=2NC3=CC=CC=C3N=2)N=CC=C1SCCC1=CC=C(C)C=C1 WKKNMRQHYCXDMP-UHFFFAOYSA-N 0.000 description 1
- KNZKATSHKYETQP-UHFFFAOYSA-N 2-[[3-methyl-4-[(4-methylphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(C)=CC=C1CSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1C KNZKATSHKYETQP-UHFFFAOYSA-N 0.000 description 1
- SKSJOWZMFXBHKU-UHFFFAOYSA-N 2-[[3-methyl-4-[(4-methylphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-6-(trifluoromethyl)-1H-benzimidazole Chemical compound C1=CC(C)=CC=C1CSC1=CC=NC(CSC=2NC3=CC(=CC=C3N=2)C(F)(F)F)=C1C SKSJOWZMFXBHKU-UHFFFAOYSA-N 0.000 description 1
- UWCWAOKQLGOZFZ-UHFFFAOYSA-N 2-[[3-methyl-4-[[3-(trifluoromethyl)phenyl]methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CN=C(CSC=2NC3=CC=CC=C3N=2)C(C)=C1SCC1=CC=CC(C(F)(F)F)=C1 UWCWAOKQLGOZFZ-UHFFFAOYSA-N 0.000 description 1
- WAPPMRIPLLEOBT-UHFFFAOYSA-N 2-[[4-(2-phenylethylsulfanyl)pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C=1C=NC(CSC=2NC3=CC=CC=C3N=2)=CC=1SCCC1=CC=CC=C1 WAPPMRIPLLEOBT-UHFFFAOYSA-N 0.000 description 1
- GMTYADCJFJWGMJ-UHFFFAOYSA-N 2-[[4-[(2,4-difluorophenyl)methylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CN=C(CSC=2NC3=CC=CC=C3N=2)C(C)=C1SCC1=CC=C(F)C=C1F GMTYADCJFJWGMJ-UHFFFAOYSA-N 0.000 description 1
- GUGOQKQAMFEQNT-UHFFFAOYSA-N 2-[[4-[(2-chloro-6-fluorophenyl)methylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CN=C(CSC=2NC3=CC=CC=C3N=2)C(C)=C1SCC1=C(F)C=CC=C1Cl GUGOQKQAMFEQNT-UHFFFAOYSA-N 0.000 description 1
- QEZAMKSQORDBPN-UHFFFAOYSA-N 2-[[4-[(4-chlorophenyl)methylsulfanyl]-3,5-dimethylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound CC1=CN=C(CSC=2NC3=CC=CC=C3N=2)C(C)=C1SCC1=CC=C(Cl)C=C1 QEZAMKSQORDBPN-UHFFFAOYSA-N 0.000 description 1
- KTICJYWDJHSWDU-UHFFFAOYSA-N 2-[[4-[(4-chlorophenyl)methylsulfanyl]-3,5-dimethylpyridin-2-yl]methylsulfanyl]-6-(difluoromethoxy)-1h-benzimidazole Chemical compound CC1=CN=C(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)C(C)=C1SCC1=CC=C(Cl)C=C1 KTICJYWDJHSWDU-UHFFFAOYSA-N 0.000 description 1
- ASXZKQONRCTFCK-UHFFFAOYSA-N 2-[[4-[(4-chlorophenyl)methylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-(2,2,2-trifluoroethoxy)-1h-benzimidazole Chemical compound C1=CN=C(CSC=2NC3=CC(OCC(F)(F)F)=CC=C3N=2)C(C)=C1SCC1=CC=C(Cl)C=C1 ASXZKQONRCTFCK-UHFFFAOYSA-N 0.000 description 1
- IROHXYDLKGLJJZ-UHFFFAOYSA-N 2-[[4-[(4-chlorophenyl)methylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-(difluoromethoxy)-1H-benzimidazole Chemical compound C1=CN=C(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)C(C)=C1SCC1=CC=C(Cl)C=C1 IROHXYDLKGLJJZ-UHFFFAOYSA-N 0.000 description 1
- VDSKNDXEBCYWDK-UHFFFAOYSA-N 2-[[4-[(4-chlorophenyl)methylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-(trifluoromethyl)-1H-benzimidazole Chemical compound C1=CN=C(CSC=2NC3=CC(=CC=C3N=2)C(F)(F)F)C(C)=C1SCC1=CC=C(Cl)C=C1 VDSKNDXEBCYWDK-UHFFFAOYSA-N 0.000 description 1
- NRYYIKOJSQKVMD-UHFFFAOYSA-N 2-[[4-[(4-chlorophenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(Cl)=CC=C1CSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1 NRYYIKOJSQKVMD-UHFFFAOYSA-N 0.000 description 1
- QEXDCKOVCCZPCP-UHFFFAOYSA-N 2-[[4-[(4-methoxyphenyl)methylsulfanyl]-3,5-dimethylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(OC)=CC=C1CSC1=C(C)C=NC(CSC=2NC3=CC=CC=C3N=2)=C1C QEXDCKOVCCZPCP-UHFFFAOYSA-N 0.000 description 1
- CJAITFICHGQZSX-UHFFFAOYSA-N 2-[[4-[(4-methoxyphenyl)methylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-(trifluoromethyl)-1h-benzimidazole Chemical compound C1=CC(OC)=CC=C1CSC1=CC=NC(CSC=2NC3=CC(=CC=C3N=2)C(F)(F)F)=C1C CJAITFICHGQZSX-UHFFFAOYSA-N 0.000 description 1
- QCNMJMOMMPTJKS-UHFFFAOYSA-N 2-[[4-[(4-methoxyphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(OC)=CC=C1CSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1 QCNMJMOMMPTJKS-UHFFFAOYSA-N 0.000 description 1
- TTWWWDCAPJNRIT-UHFFFAOYSA-N 2-[[4-[(4-methylphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(C)=CC=C1CSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1 TTWWWDCAPJNRIT-UHFFFAOYSA-N 0.000 description 1
- LXDYFEPGGMGNDT-UHFFFAOYSA-N 2-[[4-[2-(2,4-difluorophenyl)ethylsulfanyl]pyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(N=CC=1)=CC=1SCCC1=CC=C(F)C=C1F LXDYFEPGGMGNDT-UHFFFAOYSA-N 0.000 description 1
- ZBCASBNKTOEHKA-UHFFFAOYSA-N 2-[[4-[3-(2,4-difluorophenyl)propylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CN=C(CSC=2NC3=CC=CC=C3N=2)C(C)=C1SCCCC1=CC=C(F)C=C1F ZBCASBNKTOEHKA-UHFFFAOYSA-N 0.000 description 1
- CONUUOUVMNTLQY-UHFFFAOYSA-N 2-[[4-[3-(2,4-difluorophenyl)propylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-methoxy-1H-benzimidazole Chemical compound COC1=CC2=C(NC(=N2)SCC2=NC=CC(=C2C)SCCCC2=C(C=C(C=C2)F)F)C=C1 CONUUOUVMNTLQY-UHFFFAOYSA-N 0.000 description 1
- GLLCCOAKRMRSLS-UHFFFAOYSA-N 2-[[4-[3-(2,4-difluorophenyl)propylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound FC1=CC(F)=CC=C1CCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1 GLLCCOAKRMRSLS-UHFFFAOYSA-N 0.000 description 1
- HRRUKPJKMZLRIF-UHFFFAOYSA-N 2-[[4-[3-(4-chlorophenyl)propylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(C=1C)=NC=CC=1SCCCC1=CC=C(Cl)C=C1 HRRUKPJKMZLRIF-UHFFFAOYSA-N 0.000 description 1
- ZRFPFCSGFXJYKO-UHFFFAOYSA-N 2-[[4-[3-(4-fluorophenyl)propylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(C=1C)=NC=CC=1SCCCC1=CC=C(F)C=C1 ZRFPFCSGFXJYKO-UHFFFAOYSA-N 0.000 description 1
- XXDSSPYOYQMBIO-UHFFFAOYSA-N 2-[[4-[4-(2,4-difluorophenyl)butylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound FC1=CC(F)=CC=C1CCCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1 XXDSSPYOYQMBIO-UHFFFAOYSA-N 0.000 description 1
- OPQRNQPOPZXTEW-UHFFFAOYSA-N 2-[[4-[4-(2,4-difluorophenyl)butylsulfanyl]pyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(N=CC=1)=CC=1SCCCCC1=CC=C(F)C=C1F OPQRNQPOPZXTEW-UHFFFAOYSA-N 0.000 description 1
- GZZOVBJQNYPEMQ-UHFFFAOYSA-N 2-[[4-[4-(4-chlorophenyl)butylsulfanyl]-3-methoxypyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(C=1OC)=NC=CC=1SCCCCC1=CC=C(Cl)C=C1 GZZOVBJQNYPEMQ-UHFFFAOYSA-N 0.000 description 1
- YQSFMCTYBKXFKL-UHFFFAOYSA-N 2-[[4-[4-(4-fluorophenyl)butylsulfanyl]-3-methoxypyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(C=1OC)=NC=CC=1SCCCCC1=CC=C(F)C=C1 YQSFMCTYBKXFKL-UHFFFAOYSA-N 0.000 description 1
- GXZJGKSNSINDNZ-UHFFFAOYSA-N 2-[[4-[5-(2,4-difluorophenyl)pentylsulfanyl]-3-ethylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CN=C(CSC=2NC3=CC=CC=C3N=2)C(CC)=C1SCCCCCC1=CC=C(F)C=C1F GXZJGKSNSINDNZ-UHFFFAOYSA-N 0.000 description 1
- KZAYFVKMWZTLHM-UHFFFAOYSA-N 2-[[4-[5-(2,4-difluorophenyl)pentylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound FC1=CC(F)=CC=C1CCCCCSC1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1 KZAYFVKMWZTLHM-UHFFFAOYSA-N 0.000 description 1
- OXRJEMMAKATIHA-UHFFFAOYSA-N 2-[[4-[5-(2-fluoro-6-methylphenyl)pentylsulfanyl]-3,5-dimethylpyridin-2-yl]methylsulfanyl]-1H-benzimidazole Chemical compound CC=1C(=NC=C(C=1SCCCCCC1=C(C=CC=C1C)F)C)CSC1=NC2=C(N1)C=CC=C2 OXRJEMMAKATIHA-UHFFFAOYSA-N 0.000 description 1
- MQXWSECAUCIVCL-UHFFFAOYSA-N 2-[[4-[5-(4-chlorophenyl)pentylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(C=1C)=NC=CC=1SCCCCCC1=CC=C(Cl)C=C1 MQXWSECAUCIVCL-UHFFFAOYSA-N 0.000 description 1
- FMTTXPUGXIDSGN-UHFFFAOYSA-N 2-[[4-[5-(4-fluorophenyl)pentylsulfanyl]-3-methoxypyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(C=1OC)=NC=CC=1SCCCCCC1=CC=C(F)C=C1 FMTTXPUGXIDSGN-UHFFFAOYSA-N 0.000 description 1
- BZROKAKVDMNGSI-UHFFFAOYSA-N 2-[[4-[5-(4-fluorophenyl)pentylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-6-methoxy-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1SCC(C=1C)=NC=CC=1SCCCCCC1=CC=C(F)C=C1 BZROKAKVDMNGSI-UHFFFAOYSA-N 0.000 description 1
- GCKMAJWDZMVFPR-UHFFFAOYSA-N 2-[[4-[[3-(trifluoromethyl)phenyl]methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound FC(F)(F)C1=CC=CC(CSC=2C=C(CSC=3NC4=CC=CC=C4N=3)N=CC=2)=C1 GCKMAJWDZMVFPR-UHFFFAOYSA-N 0.000 description 1
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000006512 3,4-dichlorobenzyl group Chemical group [H]C1=C(Cl)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-N 3-Hydroxy-2-naphthoate Chemical compound C1=CC=C2C=C(O)C(C(=O)O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- KAXUGSRDLZFNKB-UHFFFAOYSA-N 6-(2,2-difluoroethoxy)-2-[[4-[(4-fluorophenyl)methylsulfanyl]-3,5-dimethylpyridin-2-yl]methylsulfanyl]-1H-benzimidazole Chemical compound CC1=CN=C(CSC=2NC3=CC(OCC(F)F)=CC=C3N=2)C(C)=C1SCC1=CC=C(F)C=C1 KAXUGSRDLZFNKB-UHFFFAOYSA-N 0.000 description 1
- AEPQDIQSSHKARV-UHFFFAOYSA-N 6-(difluoromethoxy)-2-[[3,5-dimethyl-4-[(4-methylphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(C)=CC=C1CSC1=C(C)C=NC(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)=C1C AEPQDIQSSHKARV-UHFFFAOYSA-N 0.000 description 1
- LVFUBYGBBZFPEH-UHFFFAOYSA-N 6-(difluoromethoxy)-2-[[3-methyl-4-[(4-methylphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(C)=CC=C1CSC1=CC=NC(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)=C1C LVFUBYGBBZFPEH-UHFFFAOYSA-N 0.000 description 1
- KXDQAJDMRHBPQI-UHFFFAOYSA-N 6-(difluoromethoxy)-2-[[4-[(2-fluorophenyl)methylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-1H-benzimidazole Chemical compound CC1=C(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)N=CC=C1SCC1=CC=CC=C1F KXDQAJDMRHBPQI-UHFFFAOYSA-N 0.000 description 1
- PUYDVYAVCSVMJF-UHFFFAOYSA-N 6-(difluoromethoxy)-2-[[4-[(4-methoxyphenyl)methylsulfanyl]-3,5-dimethylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(OC)=CC=C1CSC1=C(C)C=NC(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)=C1C PUYDVYAVCSVMJF-UHFFFAOYSA-N 0.000 description 1
- WVUWYXMGNYIVTQ-UHFFFAOYSA-N 6-(difluoromethoxy)-2-[[4-[(4-methoxyphenyl)methylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(OC)=CC=C1CSC1=CC=NC(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)=C1C WVUWYXMGNYIVTQ-UHFFFAOYSA-N 0.000 description 1
- MQULZANKEGFJJU-UHFFFAOYSA-N 6-(difluoromethoxy)-2-[[4-[(4-methylphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(C)=CC=C1CSC1=CC=NC(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)=C1 MQULZANKEGFJJU-UHFFFAOYSA-N 0.000 description 1
- PAEDYCMCBUWPRG-UHFFFAOYSA-N 6-(difluoromethylperoxy)-2-[[4-[(4-methoxyphenyl)methylsulfanyl]pyridin-2-yl]methylsulfanyl]-1H-benzimidazole Chemical compound COC1=CC=C(CSC2=CC(=NC=C2)CSC2=NC3=C(N2)C=CC(=C3)OOC(F)F)C=C1 PAEDYCMCBUWPRG-UHFFFAOYSA-N 0.000 description 1
- AOFQUSQXBYCTLW-UHFFFAOYSA-N 6-[(4-benzylsulfanyl-3-methylpyridin-2-yl)methylsulfanyl]-2,2-difluoro-5h-[1,3]dioxolo[4,5-f]benzimidazole Chemical compound CC1=C(CSC=2NC3=CC=4OC(F)(F)OC=4C=C3N=2)N=CC=C1SCC1=CC=CC=C1 AOFQUSQXBYCTLW-UHFFFAOYSA-N 0.000 description 1
- UOBZEXOFTDEJQL-UHFFFAOYSA-N 6-methoxy-2-[[4-[2-(4-methoxyphenyl)ethylsulfanyl]-3-methylpyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound C1=CC(OC)=CC=C1CCSC1=CC=NC(CSC=2NC3=CC(OC)=CC=C3N=2)=C1C UOBZEXOFTDEJQL-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- LCBVLPKCPNUJCK-UHFFFAOYSA-N CC1=C(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)N=CC=C1SC1CC1 Chemical compound CC1=C(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)N=CC=C1SC1CC1 LCBVLPKCPNUJCK-UHFFFAOYSA-N 0.000 description 1
- HHDHBXDGMNMFJK-UHFFFAOYSA-N CCCCSC1=C(C)C=NC(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)=C1C Chemical compound CCCCSC1=C(C)C=NC(CSC=2NC3=CC(OC(F)F)=CC=C3N=2)=C1C HHDHBXDGMNMFJK-UHFFFAOYSA-N 0.000 description 1
- NFKUCKDWBNGFJS-UHFFFAOYSA-N COC1=CC2=C(NC(=N2)SCC2=NC=C(C(=C2C)SCCC2=CC=C(C=C2)F)C)C=C1 Chemical compound COC1=CC2=C(NC(=N2)SCC2=NC=C(C(=C2C)SCCC2=CC=C(C=C2)F)C)C=C1 NFKUCKDWBNGFJS-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- ZHDSCPNAZAJOKO-UHFFFAOYSA-N [O]C(F)F Chemical compound [O]C(F)F ZHDSCPNAZAJOKO-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000007382 columbia agar Substances 0.000 description 1
- 208000030499 combat disease Diseases 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- HXCKCCRKGXHOBK-UHFFFAOYSA-N cycloheptane Chemical compound [CH]1CCCCCC1 HXCKCCRKGXHOBK-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- LTVOKYUPTHZZQH-UHFFFAOYSA-N difluoromethane Chemical group F[C]F LTVOKYUPTHZZQH-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960003194 meglumine Drugs 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000005244 neohexyl group Chemical group [H]C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Definitions
- R4 is hydrogen or 1-4C-alkyl
- R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly fluorine-substituted 1-4C-alkoxy, chlorodifluoroethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R3 desired at most means completely or partially substituted by fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy,
- Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy
- R5 means 1-7C-alkyl, 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, Hydroxy, 1-4C-alkoxy, halogen, nitro,
- the invention also relates to a process for the preparation of the new compounds of the formula I.
- the process is characterized in that appropriately substituted starting compounds analogous to those in European Patent No. 150 586 are reacted in a manner known per se.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compounds having the formula (I), in which R1, R2, R3, R4, R5, R6 and n have the meanings given in the description, are suitable for controlling helicobacter bacteria.
Description
VERWENDUNG VON ALKYLTHIOPYRIDINEW ZUR BEKÄMPFUNG VON HELIOBACTER-BAKTERIENUSE OF ALKYLTHIOPYRIDINEW TO COMBAT HELIOBACTER BACTERIA
Anwendungsgebiet der ErfindungField of application of the invention
Die Erfindung betrifft Verbindungen, die in der pharmazeutischen Industrie als Wirkstoffe für die Herstellung von Arzneimitteln verwendet werden sollen.The invention relates to compounds which are to be used in the pharmaceutical industry as active ingredients for the production of medicaments.
Bekannter technischer HintergrundKnown technical background
In der europäischen Patentanmeldung 150586 werden 2-(Pyridylmethylthio- bzw. -sulfinyl)-benzimidazole offenbart, die im Pyridinteil des Moleküls in 4-Position unter anderem durch Alkylthio- oder Arylthioreste substituiert sein können. Für die beschriebenen Verbindungen wird eine langanhaltende Magensäuresekretionshemmung angegeben. - In der internationalen Patentan¬ meldung W089/03830 ist beschrieben, daß sich dieselben, sowie weitere strukturähnliche Verbindungen zur Behandlung der Osteoporose eignen sollen. - In der internationalen Patentanmeldung W092/12976 werden auf bestimmte Weise substituierte 2-(Pyridylmethylthio- bzw. -sulfinyl)-benzimidazole be¬ schrieben, die gegen Helicobacter-Bakterien wirksam sein sollen und für die weiterhin offenbart ist, daß sie für die Verhütung und Behandlung einer ganzen Reihe von Erkrankungen des Magens geeignet sein sollen.European patent application 150586 discloses 2- (pyridylmethylthio- or -sulfinyl) benzimidazoles, which can be substituted in the pyridine part of the molecule in the 4-position by alkylthio or arylthio residues, among other things. Long-term gastric acid secretion inhibition is indicated for the compounds described. - In international patent application W089 / 03830 it is described that the same, as well as other structure-like compounds, are said to be suitable for the treatment of osteoporosis. - In the international patent application WO92 / 12976, substituted 2- (pyridylmethylthio- or -sulfinyl) benzimidazoles are described in a certain way, which are said to be effective against Helicobacter bacteria and for which it is furthermore disclosed that they are useful for the prevention and Treatment of a whole range of diseases of the stomach are said to be suitable.
Beschreibung der ErfindungDescription of the invention
Gegenstand der Erfindung ist die Verwendung von Verbindungen der Formel IThe invention relates to the use of compounds of the formula I.
(siehe beigefügtes Formelblatt), worin(see attached formula sheet), where
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen, Trifluor ethyl , ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor- methoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch- tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet,
R3 Wasserstoff, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder ge¬ meinsam mit R2 gewünschtenfalls ganz oder teilweise durch Fluor substi¬ tuiertes l-2C-Alky1endioxy oder Chlortrifluorethylendioxy bedeutet, R4 Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet, R5 1-7C-Alkyl, 3-7C-Cycloalkyl , 3-7C-Alkenyl, Aryl oder Aryl-l-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substi¬ tuiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoroethyl, completely or predominantly substituted by fluorine-1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-l, 1,2-trifluoroethoxy or together with R3, if desired, denotes completely or partially fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy, R3 is hydrogen, completely or predominantly fluorine-substituted 1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R2, if desired, completely or partially substituted by fluorine-1,2-alkylenedioxy or chlorotrifluoroethylene dioxy means R4 means hydrogen, 1-4C-alkyl or 1-4C-alkoxy, R5 means 1-7C-alkyl, 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or aryl-1-7C-alkyl, where aryl represents phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, oder Halogen bedeutet, R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy , or halogen, R6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, and n is the number 0 or 1, and their pharmacologically acceptable salts for the production of medicaments for combating Helicobacter bacteria.
1-4C-Alkyl steht für geradkettige oder verzweigte Alkylreste mit 1 bis 4 Kohlenstoffatomen. Beispielsweise seien genannt der Butyl-, iso-Butyl-, sec.-Butyl-, tert.-Butyl-, Propyl-, Isopropyl-, Ethyl- und der Methylrest.1-4C-Alkyl stands for straight-chain or branched alkyl radicals with 1 to 4 carbon atoms. Examples include the butyl, iso-butyl, sec-butyl, tert-butyl, propyl, isopropyl, ethyl and methyl radicals.
l-4C-Alkoxy steht für einen Rest, der neben dem Sauerstoffatom einen der vorstehend genannten 1-4C-Alkylreste enthält. Beispielsweise seien der Methoxy- und der Ethoxyrest genannt.1-4C-Alkoxy represents a radical which, in addition to the oxygen atom, contains one of the 1-4C-alkyl radicals mentioned above. The methoxy and ethoxy radicals may be mentioned, for example.
Halogen im Sinne der vorliegenden Erfindung ist Brom, Chlor und Fluor.Halogen in the sense of the present invention is bromine, chlorine and fluorine.
Als ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy seien bei¬ spielsweise der 1,2,2-Trifluorethoxy, der 2,2,3,3,3-Pentafluorpropoxy-, der Perfluorethoxy- und insbesondere der 1,1,2,2-Tetrafluorethoxy-, der Tri¬ fluormethoxy-, der 2,2,2-Trifluorethoxy- und der Difluormethoxyrest ge¬ nannt.For example, 1,2,2-trifluoroethoxy, 2,2,3,3,3-pentafluoropropoxy, perfluoroethoxy and in particular 1,1,2 may be used as wholly or predominantly fluorine-substituted 1-4C-alkoxy , 2-tetrafluoroethoxy, the trifluoromethoxy, the 2,2,2-trifluoroethoxy and the difluoromethoxy radical mentioned.
Als gewünschtenfalls ganz oder teilweise durch Fluor substituiertes 1-2C- Alkylendioxy seien beispielsweise der Methylendioxy- (-0-CH2-0-), der Ethy- lendioxy- (-0-CH2-CH2-0-), der 1,1-Difluorethylendioxy- (-0-CF2-CH2-0-),
der 1,1,2,2-Tetrafluorethylendioxy- (-0-CF2-CF2-0-) und insbesondere der Difluormethylendioxy- (-0-CF2-0-) und der 1,1,2-Trifluorethylendioxyrest (-0-CF2-CHF-0-) genannt.If desired, fully or partially substituted by fluorine-substituted 1-2C-alkylenedioxy include, for example, methylenedioxy- (-0-CH 2 -0-), ethylenedioxy- (-0-CH 2 -CH 2 -0-), the 1st , 1-difluoroethylene dioxy- (-0-CF 2 -CH 2 -0-), the 1,1,2,2-tetrafluoroethylene dioxy- (-0-CF 2 -CF 2 -0-) and in particular the difluoromethylene dioxy- (-0-CF 2 -0-) and the 1,1,2-trifluoroethylene dioxy radical (- 0-CF 2 -CHF-0-).
Wenn R2 und R3 gemeinsam gewünschtenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-AIkylendioxy oder Chlortrifluorethylendioxy bedeuten, so sind die Substituenten R2 und R3 in Nachbarpositionen - bevorzugt an den Positionen 5 und 6 - am Benzoteil des Benzimidazolringes gebunden.If R2 and R3 together, if desired, mean completely or partially substituted by fluorine-substituted 1-2C-alkylenedioxy or chlorotrifluoroethylene dioxy, the substituents R2 and R3 in adjacent positions - preferably at positions 5 and 6 - are bonded to the benzene part of the benzimidazole ring.
1-7C-Alkyl für R5 steht für geradkettige oder verzweigte Alkylreste mit 1 bis 7 Kohlenstoffatomen. Beispielsweise seien genannt der Heptyl-, Iso- heptyl- (2-Methylhexyl-), Hexyl-, Isohexyl- (2-Methylpentyl-), Neohexyl- (2,2-Dimethylbutyl-), Pentyl-, Isopentyl- (3-Methylbutyl-), Neopentyl- (2,2-Dimethylpropyl-), Butyl-, iso-Butyl-, sec.-Butyl-, tert.-Butyl-, Pro- pyl-, Isopropyl-, Ethyl- und der Methylrest.1-7C-Alkyl for R5 stands for straight-chain or branched alkyl radicals with 1 to 7 carbon atoms. Examples include heptyl, iso-heptyl (2-methylhexyl), hexyl, isohexyl (2-methylpentyl), neohexyl (2,2-dimethylbutyl), pentyl, isopentyl (3-methylbutyl) -), Neopentyl (2,2-dimethylpropyl), butyl, iso-butyl, sec-butyl, tert-butyl, propyl, isopropyl, ethyl and the methyl radical.
3-7C-Cycloalkyl steht für Cycloalkyl este mit 3 bis 7 Kohlenstoffatomen, also für den Cyclopropyl-, den Cyclobutyl-, den Cyclopentyl-, den Cyclo- hexyl- und den Cycloheptylrest.3-7C-Cycloalkyl stands for cycloalkyl este with 3 to 7 carbon atoms, that is for the cyclopropyl, the cyclobutyl, the cyclopentyl, the cyclohexyl and the cycloheptyl radical.
3-7C-Alkenyl steht für einen geradkettigen oder verzweigten Alkenylrest mit 3 bis 7 Kohlenstoffatomen. Als bevorzugte 3-7C-Alkenylreste seien der 2-Bu- tenyl-, der 3-Butenyl-, der 1-Propenyl- und der 2-Propenyl est (Allylrest) genannt.3-7C-Alkenyl stands for a straight-chain or branched alkenyl radical with 3 to 7 carbon atoms. The preferred 3-7C alkenyl radicals are the 2-butenyl, the 3-butenyl, the 1-propenyl and the 2-propenyl est (allyl radical).
Aryl-l-7C-alkyl steht für einen der vorstehend genannten 1-7C-Alkyl este, der durch einen (durch R51 und R52 substituierten) Phenylrest substituiert ist. Als beispielhafte Aryl-l-7C-alkylreste seien genannt der Benzyl-, 2-Methylbenzyl-, 3-Methylbenzyl-, 4-Nitrobenzyl-, 2,4-Dichlorbenzyl-, 3,4-Dichlorbenzyl-, 4-Methylbenzyl-, 4-Fluorbenzyl-, 2-Fluorbenzyl-, 3-Tri- fluormethylbenzyl-, 2-Chlorbenzyl-, 4-Chlorbenzyl-, 4-Methoxybenzyl-, 2,4-Dif1uorbenzyl-, 4-Trif1uor ethoxybenzyl-, 2-Chlor-6-f1uorbenzyl-, 2-Phenylethyl-, 3-Phenylpropyl-, 4-Phenylbutyl-, 4-(4-Chlorphenyl)butyl- und der 5-Phenylpentylrest.
Als Salze kommen für Verbindungen der Formel I, in denen n die Zahl 0 be¬ deutet, alle Säureadditionssalze in Betracht. Besonders erwähnt seien die pharmakologisch verträglichen Salze der in der Galenik üblicherweise ver¬ wendeten anorganischen und organischen Säuren. Pharmakologisch unverträgli¬ che Salze, die beispielsweise bei der Herstellung der erfindungsgemäßen Verbindungen im industriellen Maßstab als Verfahrensprodukte zunächst an¬ fallen können, werden durch dem Fachmann bekannte Verfahren in pharmakolo¬ gisch verträgliche Salze übergeführt. Als solche eignen sich wasserlösliche und wasserunlösliche Säureadditionssalze mit Säuren wie beispielsweise Salzsäure, Bromwasserstoffsäure, Phosphorsäure, Salpetersäure, Schwefelsäu¬ re, Essigsäure, Zitronensäure, D-Gluconsäure, Benzoesäure, 2-(4-Hydroxy- benzoyl)-benzoesäure, Buttersäure, Sulfosalicylsäure, Maleinsäure, Laurin- säure, Äpfelsäure, Fumarsäure, Bernsteinsäure, Oxalsäure, Weinsäure, Embon- säure, Stearinsäure, Toluolsulfonsäure, Methansulfonsäure oder 3-Hydroxy-2- naphtoesäure, wobei die Säuren bei der Salzherstellung - je nachdem, ob es sich um eine ein- oder mehrbasige Säure handelt und je nachdem, welches Salz gewünscht wird - im äquimolaren oder einem davon abweichenden Mengen¬ verhältnis eingesetzt werden.Aryl-1-7C-alkyl stands for one of the 1-7C-alkyl esters mentioned above, which is substituted by a phenyl radical (substituted by R51 and R52). Exemplary aryl-1-7C-alkyl radicals are the benzyl, 2-methylbenzyl, 3-methylbenzyl, 4-nitrobenzyl, 2,4-dichlorobenzyl, 3,4-dichlorobenzyl, 4-methylbenzyl, 4 -Fluorobenzyl-, 2-fluorobenzyl-, 3-trifluoromethylbenzyl-, 2-chlorobenzyl-, 4-chlorobenzyl-, 4-methoxybenzyl-, 2,4-dif1uorbenzyl-, 4-trifluoroethoxybenzyl-, 2-chloro-6- f1uorbenzyl, 2-phenylethyl, 3-phenylpropyl, 4-phenylbutyl, 4- (4-chlorophenyl) butyl and the 5-phenylpentyl radical. Suitable salts for compounds of the formula I in which n denotes the number 0 are all acid addition salts. Particular mention should be made of the pharmacologically acceptable salts of the inorganic and organic acids customarily used in galenics. Pharmacologically incompatible salts, which may initially be obtained as process products in the preparation of the compounds according to the invention on an industrial scale, are converted into pharmacologically compatible salts by processes known to the person skilled in the art. Suitable as such are water-soluble and water-insoluble acid addition salts with acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, nitric acid, sulfuric acid, acetic acid, citric acid, D-gluconic acid, benzoic acid, 2- (4-hydroxybenzoyl) benzoic acid, butyric acid, sulfosalicylic acid, Maleic acid, lauric acid, malic acid, fumaric acid, succinic acid, oxalic acid, tartaric acid, embonic acid, stearic acid, toluenesulfonic acid, methanesulfonic acid or 3-hydroxy-2-naphthoic acid, the acids used in salt production - depending on whether it is a - or polybasic acid and, depending on which salt is desired - be used in an equimolar or a different ratio.
Für Verbindungen der Formel I, in denen n die Zahl 1 bedeutet, kommen als Salze auch Salze mit Basen in Betracht. Als Beispiele für basische Salze seien Lithium-, Natrium-, Kalium-, Calcium-, Aluminium-, Magnesium-, Ti¬ tan-, Ammonium-, Meglumin- oder Guanidiniumsalze erwähnt, wobei auch hier bei der Salzherstellung die Basen im äquimolaren oder einem davon abwei¬ chenden Mengenverhältnis eingesetzt werden.For compounds of the formula I in which n is 1, salts with bases are also suitable as salts. Examples of basic salts are lithium, sodium, potassium, calcium, aluminum, magnesium, titanium, ammonium, meglumine or guanidinium salts, the bases also being here in the equimolar or in the salt production differing proportions are used.
Die ausgezeichnete Wirksamkeit von Verbindungen der Formel I und ihren Sal¬ zen gegen Helicobacter-Bakterien gestattet ihren Einsatz in der Humanmedi¬ zin als Wirkstoffe für die Behandlung von Krankheiten, die auf Helicobac¬ ter-Bakterien beruhen.The excellent activity of compounds of the formula I and their salts against Helicobacter bacteria permits their use in human medicine as active ingredients for the treatment of diseases which are based on Helicobacter bacteria.
Ein weiterer Gegenstand der Erfindung ist daher ein Verfahren zur Behand¬ lung von Säugern, insbesondere Menschen, die an Krankheiten erkrankt sind, die auf Helicobacter-Bakterien beruhen. Das Verfahren ist dadurch gekenn¬ zeichnet, daß man dem erkrankten Individuum eine therapeutisch wirksame und pharmakologisch verträgliche Menge einer oder mehrerer Verbindungen der Formel I und/oder ihrer pharmakologisch verträglichen Salze verabreicht.
Gegenstand der Erfindung sind außerdem die Verbindungen der Formel I und ihre pharmakologisch verträglichen Salze zur Anwendung bei der Behandlung von Krankheiten, die auf Helicobacter-Bakterien beruhen.The invention therefore furthermore relates to a method for the treatment of mammals, in particular humans, who are suffering from diseases which are based on Helicobacter bacteria. The method is characterized in that the diseased individual is administered a therapeutically effective and pharmacologically tolerable amount of one or more compounds of the formula I and / or their pharmacologically tolerable salts. The invention also relates to the compounds of the formula I and their pharmacologically tolerable salts for use in the treatment of diseases which are based on Helicobacter bacteria.
Ebenso umfaßt die Erfindung die Verwendung von Verbindungen der Formel I und ihren pharmakologisch verträglichen Salzen bei der Herstellung von Arz¬ neimitteln, die zur Bekämpfung solcher Krankheiten eingesetzt werden, die auf Helicobacter-Bakterien beruhen.The invention also encompasses the use of compounds of the formula I and their pharmacologically tolerable salts in the preparation of medicaments which are used to combat diseases which are based on Helicobacter bacteria.
Ein weiterer Gegenstand der Erfindung sind Arzneimittel zur Bekämpfung von Helicobacter-Bakterien, die eine oder mehrere Verbindungen der allgemeinen Formel I und/oder ihre pharmakologisch verträglichen Salze enthalten.The invention further relates to medicaments for combating Helicobacter bacteria which contain one or more compounds of the general formula I and / or their pharmacologically tolerable salts.
Desweiteren umfaßt die Erfindung Erzeugnisse, die Verpackungsmaterial und ein Arzneimittel in diesem Verpackungsmaterial betreffen, wobei das Arzneimittel wirksam bei der Bekämpfung von Helicobacter-Bakterien ist und wobei das Verpackungsmaterial einen schriftlichen Hinweis darauf enthält, daß das Arzneimittel zur Behandlung von Magen- und Darmerkrankungen geeignet ist, die im Zusammenhang mit einer Keimbesiedelung durch Helicobacter-Bakterien stehen, und wobei das Arzneimittel eine Verbindung der Formel I und/oder ein pharmakologisch verträgliches Salz davon enthält.The invention further encompasses products relating to packaging material and a medicament in said packaging material, the medicament being effective in combating Helicobacter bacteria and the packaging material containing a written indication that the medicament is suitable for the treatment of gastric and intestinal diseases which are associated with germ colonization by Helicobacter bacteria, and wherein the medicament contains a compound of formula I and / or a pharmacologically acceptable salt thereof.
Von den Helicobacter-Stämmen, gegenüber denen sich die Verbindungen der Formel I als wirksam erweisen, sei insbesondere der Stamm Helicobacter py- lori erwähnt.Of the Helicobacter strains against which the compounds of the formula I have proven to be effective, the Helicobacter pyori strain should be mentioned in particular.
Die Arzneimittel werden nach an sich bekannten, dem Fachmann geläufigen Verfahren hergestellt. Als Arzneimittel werden die pharmakologisch wirksa¬ men Verbindungen der Formel I und ihre Salze (=Wirkstoffe) entweder als solche, oder vorzugsweise in Kombination mit geeigneten pharmazeutischen Hilfsstoffen z.B. in Form von Tabletten, Dragees, Kapseln, Emulsionen, Sus¬ pensionen, Gelen oder Lösungen eingesetzt, wobei der Wirkstoffgehalt vor¬ teilhafterweise zwischen 0,1 und 95 % beträgt.
Welche Hilfsstoffe für die gewünschten Arzneimittelformulierungen geeignet sind, ist dem Fachmann aufgrund seines Fachwissens geläufig. Neben Lösemit¬ teln, Gelbildnern, Tablettenhilfsstoffen und anderen Wirkstoffträgem kön¬ nen beispielsweise Antioxidantien, Dispergiermittel, Emulgatoren, Entschäu¬ mer, Geschmackskorrigentien, Konservierungsmittel, Lösungsvermittler, Farb¬ stoffe oder Permeationspromotoren und Komplexbildner (z.B. Cyclodextrine) verwendet werden.The pharmaceuticals are produced by methods known per se and familiar to the person skilled in the art. The pharmacologically active compounds of the formula I and their salts (= active ingredients) are used as pharmaceuticals either as such or preferably in combination with suitable pharmaceutical auxiliaries, for example in the form of tablets, dragées, capsules, emulsions, suspensions, gels or solutions used, the active ingredient content advantageously being between 0.1 and 95%. The person skilled in the art is familiar with the auxiliaries which are suitable for the desired pharmaceutical formulations on the basis of his specialist knowledge. In addition to solvents, gel formers, tablet auxiliaries and other active ingredient carriers, for example antioxidants, dispersants, emulsifiers, defoamers, taste correctives, preservatives, solubilizers, colorants or permeation promoters and complexing agents (for example cyclodextrins) can be used.
Die Wirkstoffe können beispielsweise parenteral (z.B. intravenös) oder ins¬ besondere oral appliziert werden.The active substances can, for example, be administered parenterally (e.g. intravenously) or in particular orally.
Im allgemeinen werden in der Humanmedizin die Wirkstoffe in einer Tagesdo¬ sis von etwa 0,2 bis 50, vorzugsweise 1 bis 30 mg/kg Körpergewicht, ge¬ gebenenfalls in Form mehrerer, vorzugsweise 2 bis 6 Einzelgaben zur Erzie¬ lung des gewünschten Ergebnisses verabreicht.In general, the active ingredients in human medicine are administered in a daily dose of about 0.2 to 50, preferably 1 to 30 mg / kg of body weight, optionally in the form of several, preferably 2 to 6, individual doses to achieve the desired result .
In diesem Zusammenhang ist als erfindungswesentlicher Aspekt besonders zu erwähnen, daß sich die Verbindungen der Formel I, in denen n die Zahl 0 bedeutet, gegenüber Helicobacter-Bakterien bereits bei Verabfolgung solcher Dosen als wirksam erweisen, die unterhalb der Dosen liegen, die zur Erzie¬ lung einer - therapeutischen Zwecken genügenden - Magensäuresekretions em- mung eingesetzt werden müßten.In this connection, it should be mentioned as an essential aspect of the invention that the compounds of the formula I, in which n is the number 0, are effective against Helicobacter bacteria when the doses are administered, which are below the doses used for education gastric acid secretion - adequate for therapeutic purposes.
Eine Ausgestaltung (Ausgestaltung a) der Erfindung ist die Verwendung der vorstehend genannten Verbindungen der Formel I und ihrer pharmakologisch verträglichen Salze, mit Ausnahme solcher Verbindungen der Formel I und ihrer pharmakologisch verträglichen Salze, in denenOne embodiment (embodiment a) of the invention is the use of the abovementioned compounds of the formula I and their pharmacologically tolerable salts, with the exception of those compounds of the formula I and their pharmacologically tolerated salts in which
Rl Wasserstoff,R1 hydrogen,
R2 Wasserstoff, Methyl, Methoxy oder Trifluormethyl ,R2 is hydrogen, methyl, methoxy or trifluoromethyl,
R3 Wasserstoff,R3 is hydrogen,
R4 Wasserstoff oder 1-4C-Alkyl,R4 is hydrogen or 1-4C-alkyl,
R5 1-4C-Alkyl, 3-7C-Cycloalkyl , 3-4C-Alkenyl , Aryl oder Arylmethyl bedeu¬ tet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro oderR5 is 1-4C-alkyl, 3-7C-cycloalkyl, 3-4C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, Hydroxy, 1-4C-alkoxy, halogen, nitro or
Trifluormethyl und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,
R6 Wasserstoff oder 1 -4C-Al kyl und n die Zahl 0 oder 1 bedeutet.Trifluoromethyl and R52 denotes hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen, R6 is hydrogen or 1 -4C-alkyl and n is the number 0 or 1.
Eine weitere Ausgestaltung (Ausgestaltung b) der Erfindung ist dieAnother embodiment (embodiment b) of the invention is
Verwendung von Verbindungen der Formel I, worinUse of compounds of formula I, wherein
Rl Wasserstoff bedeutet,Rl is hydrogen,
R2 Wasserstoff, Methyl, Methoxy oder Trifluormethyl bedeutet,R2 represents hydrogen, methyl, methoxy or trifluoromethyl,
R3 Wasserstoff bedeutet,R3 means hydrogen,
R4 Wasserstoff oder 1-4C-A1kyl bedeutet,R4 denotes hydrogen or 1-4C-A1kyl,
R5 1-4C-Alkyl, 3-7C-Cycloalkyl , 3-4C-Alkenyl , Aryl oder Arylmethyl bedeu¬ tet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro oderR5 is 1-4C-alkyl, 3-7C-cycloalkyl, 3-4C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, Hydroxy, 1-4C-alkoxy, halogen, nitro or
Trifluormethyl und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl and R52 denotes hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff oder 1-4C-A1kyl bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.R6 is hydrogen or 1-4C-alkyl, and n is the number 0 or 1, and their pharmacologically acceptable salts for the preparation of medicaments for the control of Helicobacter bacteria.
Gegenstand der Ausgestaltung b ist beispielsweise die Verwendung folgender Verbindungen:The embodiment b relates, for example, to the use of the following compounds:
1. 2-{[(4-Benzylthio-3-methyl-2-pyridinyl)methyl]thio)-lH-benzimidazol , Schmp. 187-188PC1.2 - {[(4-benzylthio-3-methyl-2-pyridinyl) methyl] thio) -IH-benzimidazole, m.p. 187-188 P C
2. 2-{[(4-Butylthio-3-methyl-2-pyridinyl)methyl]thio)-lH-benzimidazol, Schmp. 136-137βC2. 2 - {[(4-butylthio-3-methyl-2-pyridinyl) methyl] thio) -IH-benzimidazole, m.p. 136-137 β C
3. 2-{[[4-(4-Chlorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio}-lH-benz- i idazol, Schmp. 171-172βC3. 2 - {[[4- (4-chlorobenzylthio) -3-methyl-2-pyridinyl] methyl] thio} -lH-benz-i idazole, mp 171-172 β C
4. 2-{[[4-(4-Methoxybenzylthio)-3-methyl-2-pyridinyl]methyl]thio}-lH-benz- i idazol, Schmp. 126-128"C4. 2 - {[[4- (4-methoxybenzylthio) -3-methyl-2-pyridinyl] methyl] thio} -lH-benz-i idazole, m.p. 126-128 "C
5. 2-{[[4-(4-F1uorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-lH-benz- imidazol, Schmp. 133-135°C5. 2 - {[[4- (4-F1uorbenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -lH-benzimidazole, mp 133-135 ° C
6. 2-{[[4-(4-Methylbenzylthio)-3-methyl-2-pyridinyl]methyl]thio}-lH-benz- imidazol, Schmp. 178-180βC
7. 2-{[[4-(2-F1uorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-lH-benz- i idazol, Schmp. 179-181°C6. 2 - {[[4- (4-Methylbenzylthio) -3-methyl-2-pyridinyl] methyl] thio} -lH-benzimidazole, m.p. 178-180 β C 7. 2 - {[[4- (2-F1uorbenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -lH-benz-i idazole, mp 179-181 ° C
8. 2-{[(4-Benzylthio-3-methyl-2-pyridinyl)methyl]thio)-5-methoxy-lH-benz- i idazol, Schmp. 101-103βC.8. 2 - {[(4-benzylthio-3-methyl-2-pyridinyl) methyl] thio) -5-methoxy-lH-benz-i idazole, m.p. 101-103 β C.
9. 2-{[(4-Benzylthio-2-pyridinyl)methyl]thio}-lH-benzimidazol9. 2 - {[(4-benzylthio-2-pyridinyl) methyl] thio} -lH-benzimidazole
10. 2-{[(4-Butylthio-2-pyridinyl)methyl]thio}-lH-benzimidazol10. 2 - {[(4-butylthio-2-pyridinyl) methyl] thio} -IH-benzimidazole
11. 2-{[[4-(4-Chlorbenzylthio)-2-pyridinyl]methyl]thio)-lH-benzimidazol11. 2 - {[[4- (4-chlorobenzylthio) -2-pyridinyl] methyl] thio) -IH-benzimidazole
12. 2-{[[4-(4-Methoxybenzylthio)-2-pyridinyl]methyl]thio}-lH-benzimidazol12. 2 - {[[4- (4-methoxybenzylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
13. 2-{[[4-(4-F1uorbenzylthio)-2-pyridinyl]methyl]thio}-lH-benzimidazol13. 2 - {[[4- (4-F1uorbenzylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
14. 2-{[[4-(4-Methylbenzylthio)-2-pyridinyl]methyl]thio)-lH-benzimidazol14. 2 - {[[4- (4-Methylbenzylthio) -2-pyridinyl] methyl] thio) -IH-benzimidazole
15. 2-{[[4-(2-F1uorbenzylthio)-2-pyridinyl]methyl]thio}-lH-benzimidazol15. 2 - {[[4- (2-F1uorbenzylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
16. 2-{[(4-Benzylthio-2-pyridinyl)methyl]thio}-5-methoxy-lH-benzimidazol16. 2 - {[(4-Benzylthio-2-pyridinyl) methyl] thio} -5-methoxy-1H-benzimidazole
17. 2-{[(4-Benzylthio-3,5-dimethyl-2-pyridinyl)methyl]thio)-lH-benzimidazol17. 2 - {[(4-Benzylthio-3,5-dimethyl-2-pyridinyl) methyl] thio) -IH-benzimidazole
18. 2-{[(4-Butylthio-3,5-dimethyl-2-pyridinyl)methyl]thio}-lH-benzimidazol18. 2 - {[(4-butylthio-3,5-dimethyl-2-pyridinyl) methyl] thio} -IH-benzimidazole
19. 2-{[[4-(4-Chlorbenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio}-lH- benzimidazol19. 2 - {[[4- (4-chlorobenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio} -lH-benzimidazole
20. 2-{[[4-(4-Methoxybenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio}-lH- benzimidazol20. 2 - {[[4- (4-methoxybenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio} -IH-benzimidazole
21. 2-{[[4-(4-F1uorbenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio}-lH- benzimidazol21. 2 - {[[4- (4-F1uorbenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio} -IH-benzimidazole
22. 2-{[[4-(4-Methylbenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio)-lH- benzimidazol22. 2 - {[[4- (4-Methylbenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio) -IH-benzimidazole
23. 2-{[[4-(2-F1uorbenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio)-lH- benzimidazol23. 2 - {[[4- (2-F1uorbenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio) -IH-benzimidazole
24. 2-{[(4-Benzylthio-3,5-dimethyl-2-pyridinyl)methyl]thio}-5-methoxy-lH- benzimidazol24. 2 - {[(4-benzylthio-3,5-dimethyl-2-pyridinyl) methyl] thio} -5-methoxy-1H-benzimidazole
25. 2-{[(4-Isopropylthio-3-methyl-2-pyridinyl)methyl]thio}-lH-benzimidazol25. 2 - {[(4-isopropylthio-3-methyl-2-pyridinyl) methyl] thio} -IH-benzimidazole
26. 2-{[(3-Methyl-4-propylthio-2-pyridinyl)methyl]thio)-lH-benzimidazol26. 2 - {[(3-methyl-4-propylthio-2-pyridinyl) methyl] thio) -IH-benzimidazole
27. 2-{[(3-Methyl-4-pentylthio-2-pyridinyl)methyl]thio}-lH-benzimidazol27. 2 - {[(3-methyl-4-pentylthio-2-pyridinyl) methyl] thio} -IH-benzimidazole
28. 2-{[(4-Cyclopentylthio-3-methyl-2-pyridinyl)methyl]thio)-lH-benzimida- zol28. 2 - {[(4-Cyclopentylthio-3-methyl-2-pyridinyl) methyl] thio) -IH-benzimidazole
29. 2-{[(4-Cyclopropylthio-3-methyl-2-pyridinyl)methyl]thio)-lH-benzimida- zol29. 2 - {[(4-Cyclopropylthio-3-methyl-2-pyridinyl) methyl] thio) -IH-benzimidazole
30. 2-{[(4-Cyclohexylthio-3-methyl-2-pyridinyl)methyl]thio)-lH-benzimida- zol30. 2 - {[(4-cyclohexylthio-3-methyl-2-pyridinyl) methyl] thio) -IH-benzimidazole
31. 2-{[(4-Allylthio-3-methyl-2-pyridinyl)methyl]thio}-lH-benzimidazol
32. 2-{[ (3-Methyl -4- (2-methyl -al lyl thio) -2-pyridi nyl )methyl ]thio)-lH-benz- i idazol31. 2 - {[(4-allylthio-3-methyl-2-pyridinyl) methyl] thio} -IH-benzimidazole 32. 2 - {[(3-Methyl -4- (2-methyl-allylthio) -2-pyridinyl) methyl] thio) -IH-benz-i idazole
33. 2-{[(4-Benzylthio-3-methy1-2-pyridinyl)methyl]thio)-5-trifluormethyl- lH-benzimidazol33. 2 - {[(4-Benzylthio-3-methy1-2-pyridinyl) methyl] thio) -5-trifluoromethyl-1H-benzimidazole
34. 2-{[(4-Butylthio-3-methyl-2-pyridinyl)methyl]thio)-5-trifluormethyl-1H- benzi idazol34. 2 - {[(4-butylthio-3-methyl-2-pyridinyl) methyl] thio) -5-trifluoromethyl-1H-benzide idazole
35. 2-{[[4-(4-Chlorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio}-5-triflu- ormethyl-lH-benzimidazol35. 2 - {[[4- (4-Chlorobenzylthio) -3-methyl-2-pyridinyl] methyl] thio} -5-trifluoromethyl-1H-benzimidazole
36. 2-{[[4-(4-Methoxybenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-tri- fluormethyl-lH-benzimidazol36. 2 - {[[4- (4-Methoxybenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5-trifluoromethyl-1H-benzimidazole
37. 2-{[[4-(4-F1uorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-triflu¬ ormethyl-lH-benzimidazol37. 2 - {[[4- (4-F1uorbenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5-trifluoromethyl-1H-benzimidazole
38. 2-{[[4-(4-Methylbenzylthio)-3-methyl-2-pyridinyl]methyl]thio}-5-triflu- ormethyl-lH-benzimidazol38. 2 - {[[4- (4-Methylbenzylthio) -3-methyl-2-pyridinyl] methyl] thio} -5-trifluoromethyl-1H-benzimidazole
39. 2-{[[4-(2-F1uorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-triflu- ormethyl-lH-benzimidazol39. 2 - {[[4- (2-F1uorbenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5-trifluoromethyl-1H-benzimidazole
40. 2-{[[4-(3-Trifluormethylbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)- lH-benzimidazol40. 2 - {[[4- (3-Trifluoromethylbenzylthio) -3-methyl-2-pyridinyl] methyl] thio) - 1H-benzimidazole
41. 2-{[[4-(3-Trifluormethylbenzylthio)-2-pyridinyl]methyl]thio)-lH-benz- imidazol41. 2 - {[[4- (3-Trifluoromethylbenzylthio) -2-pyridinyl] methyl] thio) -IH-benzimidazole
42. 2-{[[4-(2,4-Difluorbenzylthio)-3-methyl-2-pyridinyl]methyl]-thio)- lH-benzimidazol, Schmp. 160-161βC42. 2 - {[[4- (2,4-difluorobenzylthio) -3-methyl-2-pyridinyl] methyl] thio) - 1H-benzimidazole, m.p. 160-161 β C
43. 2-{[[4-(2-Chlor-6-fluorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)- lH-benzimidazol, Schmp. 177-179βC43. 2 - {[[4- (2-chloro-6-fluorobenzylthio) -3-methyl-2-pyridinyl] methyl] thio) - 1H-benzimidazole, mp 177-179 β C
44. 2-{[[4-(2-Chlor-6-fluorbenzylthio)-2-pyridinyl]methyl]thio)-lH-benz- i idazol44. 2 - {[[4- (2-chloro-6-fluorobenzylthio) -2-pyridinyl] methyl] thio) -IH-benz-i idazole
45. 2-{[[4-(2-Chlor-6-fluorbenzylthio)-3,5-dimethyl-2-pyridinyljmethyl]- thio)-lH-benzimidazol und ihrer Salze.45. 2 - {[[4- (2-chloro-6-fluorobenzylthio) -3,5-dimethyl-2-pyridinyljmethyl] thio) -lH-benzimidazole and its salts.
Eine weitere Ausgestaltung (Ausgestaltung c) der Erfindung ist dieAnother embodiment (embodiment c) of the invention is
Verwendung von Verbindungen der Formel I, worinUse of compounds of formula I, wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor- ethoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch-
tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet,R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly fluorine-substituted 1-4C-alkoxy, chlorodifluoroethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R3 desired at most means completely or partially substituted by fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy,
R3 ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordi- fluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R2 ge¬ wünschtenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-A1- kylendioxy oder Chlortrifluorethylendioxy bedeutet,R3 completely or predominantly substituted by fluorine-1C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1, 2-trifluoroethoxy or together with R2, if desired, completely or partially by fluorine-substituted 1-2C-A1-kylenedioxy or chlorotrifluoroethylenedioxy means
R4 Wasserstoff oder 1-4C-Alkyl bedeutet,R4 represents hydrogen or 1-4C-alkyl,
R5 1-7C-Alkyl, 3-7C-Cycloalkyl , 3-7C-Alkenyl , Aryl oder Arylmethyl bedeu¬ tet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 is 1-7C-alkyl, 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, Hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff oder 1-4C-Alkyl bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.R6 is hydrogen or 1-4C-alkyl, and n is the number 0 or 1, and their pharmacologically tolerable salts for the preparation of medicaments for combating Helicobacter bacteria.
Eine weitere Ausgestaltung (Ausgestaltung d) der Erfindung ist dieAnother embodiment (embodiment d) of the invention is
Verwendung von Verbindungen der Formel I, worinUse of compounds of formula I, wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet,R3 means hydrogen,
R4 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,R4 denotes hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 Aryl-2-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 is aryl-2-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.
Eine weitere Ausgestaltung (Ausgestaltung e) der Erfindung ist dieR6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy and n is the number 0 or 1, and their pharmacologically acceptable salts for the preparation of medicaments for combating Helicobacter bacteria. Another embodiment (embodiment e) of the invention is
Verwendung von Verbindungen der Formel I, worinUse of compounds of formula I, wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet, einer der Substituenten R4 und R6 l-4C-Alkoxy und der andere Wasserstoff oder 1-4C-Alkyl bedeutet,R3 is hydrogen, one of the substituents R4 and R6 is 1-4C-alkoxy and the other is hydrogen or 1-4C-alkyl,
R5 1-7C-Alkyl, 3-7C-Cycloalkyl , 3-7C-Alkenyl , Aryl oder Arylmethyl bedeu¬ tet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 means 1-7C-alkyl, 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, Hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen, and n is the number 0 or 1, and their pharmacologically tolerable salts for the preparation of medicaments for combating Helicobacter bacteria.
Eine weitere Ausgestaltung (Ausgestaltung f) der Erfindung ist die Verwen¬ dung von Verbindungen der Formel I, worin Rl, R2 und R3 die für die Ausge¬ staltung c und R4, R5, R6 und n die für die Ausgestaltung d angegebenen Be¬ deutungen haben, und ihren pharmakologisch verträglichen Salzen zur Her¬ stellung von Arzneimitteln für die Bekämpfung von Helicobacter-Bakterien.A further embodiment (embodiment f) of the invention is the use of compounds of the formula I in which R 1, R 2 and R 3 have the meanings given for the embodiment c and R 4, R 5, R 6 and n have the meanings given for the embodiment d have, and their pharmacologically acceptable salts for the manufacture of medicaments for combating Helicobacter bacteria.
Die allgemeine Formel I mit ihren Substituentenbedeutungen umfaßt einer¬ seits Teile bekannter allgemeiner Formeln (z.B. W089/03830), andererseits aber auch neue, durch allgemeine Formeln definierbare Verbindungen. Gegen¬ stand der Erfindung sind daher auch solche neuen Verbindungen der Formel I, worinThe general formula I with its substituent meanings on the one hand includes parts of known general formulas (e.g. WO89 / 03830), but on the other hand also new compounds which can be defined by general formulas. The invention therefore also relates to such new compounds of the formula I in which
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor- methoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch¬ tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet,
R3 Wasserstoff, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder ge¬ meinsam mit R2 gewünschtenfalls ganz oder teilweise durch Fluor substi¬ tuiertes 1-2C-A1kylendioxy oder Chlortrifluorethylendioxy bedeutet,R1 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly substituted by fluorine, 1-4C-alkoxy, chlorodifluoromethoxy , 2-chloro-l, l, 2-trifluoroethoxy or together with R3, if desired, completely or partially by fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy, R3 is hydrogen, completely or predominantly fluorine-substituted 1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R2, if desired, completely or partially substituted by fluorine-substituted 1-2C-alkylenedioxy or chlorotrifluoroethylene dioxy means
R4 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,R4 denotes hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 Aryl-4-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 is aryl-4-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihre Salze.R6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, and n is 0 or 1, and their salts.
Gegenstand der Erfindung sind außerdem solche neuen Verbindungen der FormelThe invention also relates to such new compounds of the formula
I, worinI, in which
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor- methoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch¬ tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet,R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly fluorine-substituted 1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-l, 1,2-trifluoroethoxy or together with R3 if desired, completely or partially means fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy,
R3 Wasserstoff, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder ge¬ meinsam mit R2 gewünschtenfalls ganz oder teilweise durch Fluor substi¬ tuiertes 1-2C-A1kylendioxy oder Chlortrifluorethylendioxy bedeutet,R3 is hydrogen, completely or predominantly substituted by fluorine-1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R2, if desired, completely or partially substituted by fluorine-substituted 1-2C-alkylenedioxy or chlorotrifluoroethylene dioxy means
R4 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,R4 denotes hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 3-7C-Cycloalkyl, 3-7C-Alkenyl , Aryl oder Aryl-l-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobeiR5 is 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or aryl-1-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and wherein
R51 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro, Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,R51 is 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro, trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, und
n die Zahl 0 oder 1 bedeutet, und ihre Salze, wobei die Verbindungen der Formel I und ihre Salze ausgeschlossen sind, in denenR6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, and n denotes the number 0 or 1, and their salts, the compounds of the formula I and their salts being excluded, in which
Rl Wasserstoff,R1 hydrogen,
R2 Wasserstoff, Methyl, Methoxy oder Trifluormethyl,R2 is hydrogen, methyl, methoxy or trifluoromethyl,
R3 Wasserstoff,R3 is hydrogen,
R4 Wasserstoff oder 1-4C-A kyl ,R4 is hydrogen or 1-4C-alkyl,
R5 3-7C-Cycloalkyl, 3-7C-Alkenyl , Aryl oder Arylmethyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro oder Trifluorme¬ thyl und R52 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy oder Halogen bedeutet,R5 is 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, Nitro or trifluoromethyl and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff oder 1-4C-A1kyl und n die Zahl 0 oder 1 bedeutet.R6 is hydrogen or 1-4C-alkyl and n is the number 0 or 1.
Gegenstand der Erfindung sind innerhalb der Ausgestaltung c solche neuenThe object of the invention within the embodiment c is such new ones
Verbindungen der Formel I, worinCompounds of formula I, wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor- methoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch¬ tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet,R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly fluorine-substituted 1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R3 if desired, completely or partially means fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy,
R3 ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordi- fluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R2 ge¬ wünschtenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-A1- kylendioxy oder Chlortrifluorethylendioxy bedeutet,R3 completely or predominantly substituted by fluorine-1C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1, 2-trifluoroethoxy or together with R2, if desired, completely or partially by fluorine-substituted 1-2C-A1-kylenedioxy or chlorotrifluoroethylenedioxy means
R4 Wasserstoff oder 1-4C-Alkyl bedeutet,R4 represents hydrogen or 1-4C-alkyl,
R5 3-7C-Cycloalkyl , 3-7C-Alkenyl, Aryl oder Arylmethyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro, Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-A1kyl, l-4C-Alkoxy oder Halogen bedeutet,R5 is 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, Nitro, trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff oder 1-4C-A1kyl bedeutet,
und n die Zahl 0 oder 1 bedeutet, und ihre Salze.R6 represents hydrogen or 1-4C-A1kyl, and n represents the number 0 or 1, and their salts.
Gegenstand der Erfindung sind innerhalb der Ausgestaltung c weiterhin die folgenden neuen Verbindungen:Within the scope of embodiment c, the invention furthermore relates to the following new compounds:
46. 2-[[(4-Benzylthio-3-methyl-2-pyridinyl)methyl]thio]-5-difluormethoxy- lH-benzimidazol , Schmp. 154-156βC46. 2 - [[(4-Benzylthio-3-methyl-2-pyridinyl) methyl] thio] -5-difluoromethoxy-1H-benzimidazole, mp. 154-156 β C
47. 2,2-Difluor-6-{[(4-benzylthio-3-methyl-2-pyridinyl)methyl]thio}-5H- [l,3]-dioxolo[4,5-f]benzimidazol , Schmp. 207-208°C47. 2,2-difluoro-6 - {[(4-benzylthio-3-methyl-2-pyridinyl) methyl] thio} -5H- [1,3] -dioxolo [4,5-f] benzimidazole, mp. 207-208 ° C
48. 2-[[(4-Benzylthio-3-methyl-2-pyridinyl)methyl]thio]-5-(2,2,2-trifluor- ethoxy)-lH-benzimidazol , Schmp. 85-87βC.48. 2 - [[(4-Benzylthio-3-methyl-2-pyridinyl) methyl] thio] -5- (2,2,2-trifluoroethoxy) -lH-benzimidazole, mp. 85-87 β C.
49. 2-{[(4-Butylthio-3-methyl-2-pyridinyl)methyl]thio)-5-difluormethoxy- lH-benzimidazol49. 2 - {[(4-butylthio-3-methyl-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benzimidazole
50. 2-{[[4-(4-Chlorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-diflu¬ ormethoxy-lH-benzimidazol50. 2 - {[[4- (4-chlorobenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5-difluoromethoxy-1H-benzimidazole
51. 2-{[[4-(4-Methoxybenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-di- fluormethoxy-lH-benzimidazol51. 2 - {[[4- (4-Methoxybenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5-di-fluoromethoxy-1H-benzimidazole
52. 2-{[[4-(4-F1uorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-diflu¬ ormethoxy-lH-benzimidazol52. 2 - {[[4- (4-F1uorbenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5-difluoromethoxy-1H-benzimidazole
53. 2-{[[4-(4-Methylbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-di- fluormethoxy-lH-benzimidazol53. 2 - {[[4- (4-Methylbenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5-di-fluoromethoxy-1H-benzimidazole
54. 2-{[[4-(2-Fluorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-diflu¬ ormethoxy-lH-benzimidazol54. 2 - {[[4- (2-fluorobenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5-difluoromethoxy-1H-benzimidazole
55. 2-{[(4-Benzylthio-2-pyridinyl)methyl]thio)-5-difluormethoxy-lH-benz- i idazol55. 2 - {[(4-Benzylthio-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benz-i idazole
56. 2-{[(4-Butylthio-2-pyridinyl)methyl]thio)-5-difluormethoxy-lH-benz- imidazol56. 2 - {[(4-butylthio-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benzimidazole
57. 2-{[[4-(4-Chlorbenzylthio)-2-pyridinyl]methyl]thio)-5-difluormeth¬ oxy-lH-benzimidazol57.2 - {[[4- (4-Chlorobenzylthio) -2-pyridinyl] methyl] thio) -5-difluoromethoxy-1H-benzimidazole
58. 2-{[[4-(4-Methoxybenzylthio)-2-pyridinyl]methyl]thio)-5-difluormeth¬ oxy-lH-benzimidazol58. 2 - {[[4- (4-methoxybenzylthio) -2-pyridinyl] methyl] thio) -5-difluoromethoxy oxy-1H-benzimidazole
59. 2-{[[4-(4-F1uorbenzylthio)-2-pyridinyl]methyl]thio)-5-difluormeth- oxy-lH-benzi idazol59. 2 - {[[4- (4-F1uorbenzylthio) -2-pyridinyl] methyl] thio) -5-difluoromethoxy-1H-benzi idazole
60. 2-{[[4-(4-Methylbenzylthio)-2-pyridinyl]methyl]thio)-5-difluormeth- oxy-lH-benzimidazol
61. 2-{[[4-(2-Fluorbenzylthio)-2-pyridinylj ethyl]thio)-5-difluormeth¬ oxy-lH-benzimidazol60. 2 - {[[4- (4-Methylbenzylthio) -2-pyridinyl] methyl] thio) -5-difluoromethoxy-1H-benzimidazole 61. 2 - {[[4- (2-fluorobenzylthio) -2-pyridinylethyl] thio) -5-difluoromethoxy-1H-benzimidazole
62. 2-{[(4-Benzylthio-3,5-dimethyl-2-pyridinyl)methyl]thio)-5-difluor¬ methoxy-lH-benzimidazol62. 2 - {[(4-benzylthio-3,5-dimethyl-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benzimidazole
63. 2-{[(4-Butylthio-3,5-dimethyl-2-pyridinyl)methyl]thio)-5-difluor¬ methoxy-lH-benzimidazol63. 2 - {[(4-butylthio-3,5-dimethyl-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benzimidazole
64. 2-{[[4-(4-Chlorbenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio}-5- difluormethoxy-lH-benzimidazol64. 2 - {[[4- (4-chlorobenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio} -5-difluoromethoxy-1H-benzimidazole
65. 2-{[[4-(4-Methoxybenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio)-5- difluormethoxy-lH-benzimidazol65. 2 - {[[4- (4-methoxybenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio) -5-difluoromethoxy-1H-benzimidazole
66. 2-{[[4-(4-Fluorbenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio)-5- difluor ethoxy-lH-benzimidazol66. 2 - {[[4- (4-fluorobenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio) -5-difluoroethoxy-1H-benzimidazole
67. 2-{[[4-(4-Methylbenzylthio)-3,5-dimethyl-2-pyridinyl]methyl]thio}- 5-difluormethoxy-lH-benzimidazol67. 2 - {[[4- (4-Methylbenzylthio) -3,5-dimethyl-2-pyridinyl] methyl] thio} - 5-difluoromethoxy-1H-benzimidazole
68. 2-{[[4-(2-Fluorbenzylthio)-3,5-dimethyl-2-pyridinyljmethyl]thio)-5- difluormethoxy-lH-benzimidazol68. 2 - {[[4- (2-fluorobenzylthio) -3,5-dimethyl-2-pyridinyljmethyl] thio) -5-difluoromethoxy-1H-benzimidazole
69. 2-{[(4-Isopropylthio-3-methyl-2-pyridinyl)methyl]thio)-5-difluor- methoxy-lH-benzimidazol69. 2 - {[(4-isopropylthio-3-methyl-2-pyridinyl) methyl] thio) -5-difluoro-methoxy-1H-benzimidazole
70. 2-{[(3-Methyl-4-propylthio-2-pyridinyl)methyl]thio)-5-difluormeth- oxy-lH-benzi idazol70. 2 - {[(3-Methyl-4-propylthio-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benzi idazole
71. 2-{[(3-Methyl-4-pentylthio-2-pyridinyl)methyl]thio)-5-difluormeth¬ oxy-lH-benzimidazol71.2 - {[(3-methyl-4-pentylthio-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benzimidazole
72. 2-{[(4-Cyclopentylthio-3-methyl-2-pyridinylJmethyl]thio)-5-difluor- methoxy-lH-benzimidazol72. 2 - {[(4-Cyclopentylthio-3-methyl-2-pyridinyl-methyl] thio) -5-difluoro-methoxy-1H-benzimidazole
73. 2-{[(4-Cyclopropylthio-3-methyl-2-pyridinyl)methyl]thio)-5-difluor¬ methoxy-lH-benzimidazol73. 2 - {[(4-Cyclopropylthio-3-methyl-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benzimidazole
74. 2-{[(4-Cyclohexylthio-3-methyl-2-pyridinyl)methyl]thio)-5-difluor- methoxy-lH-benzimidazol74. 2 - {[(4-Cyclohexylthio-3-methyl-2-pyridinyl) methyl] thio) -5-difluoro-methoxy-1H-benzimidazole
75. 2-{[(4-Allylthio-3-methyl-2-pyridinyl)methyl]thio)-5-difluormethoxy- lH-benzimidazol75. 2 - {[(4-allylthio-3-methyl-2-pyridinyl) methyl] thio) -5-difluoromethoxy-1H-benzimidazole
76. 2-{[(3-Methyl-4-(2-methyl-allylthio)-2-pyridinyl)methyl]thio)-5-di- fluormethoxy-lH-benzimidazol76. 2 - {[(3-Methyl-4- (2-methyl-allylthio) -2-pyridinyl) methyl] thio) -5-di-fluoromethoxy-1H-benzimidazole
77. 2-{[(4-Butylthio-3-methyl-2-pyridinyl)methyl]thio)-5-(2,2,2-trifluor- ethoxy)-lH-benzimidazol77. 2 - {[(4-Butylthio-3-methyl-2-pyridinyl) methyl] thio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
78. 2-{[[4-(4-Chlorbenzylthio)-3-methyl-2-pyridinyl]methyl]thio)-5-(2,2,2- trifluorethoxy)-lH-benzimidazol
79. 2-{[[4-(4-Methoxybenzylthio)-3-methyl-2-pyridinyljmethyljthio)-5- (2,2,2-trifluorethoxy)-lH-benzimidazol78. 2 - {[[4- (4-Chlorobenzylthio) -3-methyl-2-pyridinyl] methyl] thio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole 79. 2 - {[[4- (4-Methoxybenzylthio) -3-methyl-2-pyridinyljmethyljthio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
80. 2-{[[4-(4-Fluorbenzylthio)-3-methyl-2-pyridinyljmethyl]thio)-5-(2,2,2- trifluorethoxy)-lH-benzimidazol80. 2 - {[[4- (4-fluorobenzylthio) -3-methyl-2-pyridinyljmethyl] thio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
81. 2-{[[4-(4-Methylbenzylthio)-3-methyl-2-pyridinylj ethyl]thio)-5- (2,2,2-trifluorethoxy)-lH-benzimidazol81. 2 - {[[4- (4-Methylbenzylthio) -3-methyl-2-pyridinyljethyl] thio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
82. 2-{[[4-(2-Fluorbenzylthio)-3-methyl-2-pyridinyljmethyljthio)-5-(2,2,2- trifluorethoxy)-lH-benzimidazol82. 2 - {[[4- (2-fluorobenzylthio) -3-methyl-2-pyridinyljmethyljthio) -5- (2,2,2-trifluoroethoxy) -lH-benzimidazole
83. 2-{[(4-Benzylthio-2-pyridinyl)methyljthio)-5-(2,2,2-trifluorethoxy)-5- (2,2,2-trifluorethoxy)-lH-benzimidazol83. 2 - {[(4-Benzylthio-2-pyridinyl) methyljthio) -5- (2,2,2-trifluoroethoxy) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
84. 2-{[(4-Butylthio-2-pyridinyl)methyljthio}-5-(2,2,2-trifluorethoxy)-1H- benzimidazol84. 2 - {[(4-butylthio-2-pyridinyl) methyljthio} -5- (2,2,2-trifluoroethoxy) -1H-benzimidazole
85. 2-{[[4-(4-Chlorbenzylthio)-2-pyridinyljmethyl]thio}-5-(2,2,2-trifluor- ethoxy)-lH-benzimidazol85. 2 - {[[4- (4-Chlorobenzylthio) -2-pyridinyljmethyl] thio} -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
86. 2-{[[4-(4-Methoxybenzylthio)-2-pyridinyljmethyljthio}-5-(2,2,2-tri- fluorethoxy)-lH-benzimidazol86. 2 - {[[4- (4-Methoxybenzylthio) -2-pyridinyljmethyljthio} -5- (2,2,2-tri-fluoroethoxy) -IH-benzimidazole
87. 2-{[[4-(4-Fluorbenzylthio)-2-pyridinyljmethyljthio}-5-(2,2,2-trifluor- ethoxy)-lH-benzimidazol87. 2 - {[[4- (4-fluorobenzylthio) -2-pyridinyljmethyljthio} -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
88. 2-{[[4-(4-Methylbenzylthio)-2-pyridinyljmethyl]thio}-5-(2,2,2-tri- fluorethoxy)-lH-benzimidazol88. 2 - {[[4- (4-Methylbenzylthio) -2-pyridinyljmethyl] thio} -5- (2,2,2-tri-fluoroethoxy) -IH-benzimidazole
89. 2-{[[4-(2-Fluorbenzylthio)-2-pyridinyljmethyl thio)-5-(2,2,2-trifluor- ethoxy)-lH-benzimidazol89. 2 - {[[4- (2-Fluorobenzylthio) -2-pyridinylmethylthio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
90. 2-{[(4-Benzylthio-3,5-dimethyl-2-pyridinyl)methyljthio)-5-(2,2,2-tri- fluorethoxy)-lH-benzimidazol90. 2 - {[(4-Benzylthio-3,5-dimethyl-2-pyridinyl) methyljthio) -5- (2,2,2-tri-fluoroethoxy) -IH-benzimidazole
91. 2-{[(4-Butylthio-3,5-dimethyl-2-pyridinyl)methyljthio)-5-(2,2,2-tri- fluorethoxy)-lH-benzimidazol91. 2 - {[(4-Butylthio-3,5-dimethyl-2-pyridinyl) methyljthio) -5- (2,2,2-tri-fluoroethoxy) -IH-benzimidazole
92. 2-{[[4-(4-Chlorbenzylthio)-3,5-dimethyl-2-pyridinyljmethyljthio)-5- (2,2,2-trifluorethoxy)-lH-benzimidazol92. 2 - {[[4- (4-Chlorobenzylthio) -3,5-dimethyl-2-pyridinyljmethyljthio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
93. 2-{[[4-(4-Methoxybenzylthio)-3,5-dimethyl-2-pyridinyljmethyljthio)-5- (2,2,2-trifluorethoxy)-lH-benzimidazol93. 2 - {[[4- (4-Methoxybenzylthio) -3,5-dimethyl-2-pyridinyljmethyljthio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
94. 2-{[[4-(4-Fluorbenzylthio)-3,5-dimethyl-2-pyridinyljmethyljthio)-5- (2,2,2-trifluorethoxy)-lH-benzimidazol94. 2 - {[[4- (4-fluorobenzylthio) -3,5-dimethyl-2-pyridinyljmethyljthio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
95. 2-{[[4-(4-Methylbenzylthio)-3,5-dimethyl-2-pyridinyljmethyljthio)-5- (2,2,2-trifluorethoxy)-lH-benzimidazol95. 2 - {[[4- (4-Methylbenzylthio) -3,5-dimethyl-2-pyridinyljmethyljthio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
96. 2-{[[4-(2-Fluorbenzylthio)-3,5-dimethyl-2-pyridinyljmethyljthio}-5- (2,2,2-trifluorethoxy)-lH-benzimidazol
97. 2-{[(4-Isopropylthio-3-methyl-2-pyridinyl)methyljthio}-5-(2,2,2-tri- fluorethoxy)-lH-benzimidazol96. 2 - {[[4- (2-Fluorobenzylthio) -3,5-dimethyl-2-pyridinyljmethyljthio} -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole 97. 2 - {[(4-isopropylthio-3-methyl-2-pyridinyl) methyljthio} -5- (2,2,2-tri-fluoroethoxy) -IH-benzimidazole
98. 2-{[(3-Methyl-4-propylthio-2-pyridinylJmethyljthio}-5-(2,2,2-trifluor¬ ethoxy)-lH-benzimidazol98. 2 - {[(3-methyl-4-propylthio-2-pyridinylmethyljthio} -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
99. 2-{[(3-Methyl-4-pentylthio-2-pyridinyl)methyljthio)-5-(2,2,2-trifluor¬ ethoxy)-lH-benzimidazol99. 2 - {[(3-methyl-4-pentylthio-2-pyridinyl) methyljthio) -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
100. 2-{[(4-Cyclopentylthio-3-methyl-2-pyridinylJmethyljthio}-5-(2,2,2-tri- fluorethoxy)-lH-benzimidazol100. 2 - {[(4-Cyclopentylthio-3-methyl-2-pyridinyl-methylmthio} -5- (2,2,2-tri-fluoroethoxy) -IH-benzimidazole
101. 2-{[(4-Cyclopropylthio-3-methyl-2-pyridinylJmethyljthio}-5-(2,2,2-tri- fluorethoxy)-lH-benzimidazol101. 2 - {[(4-Cyclopropylthio-3-methyl-2-pyridinylmethyljthio} -5- (2,2,2-tri-fluoroethoxy) -IH-benzimidazole
102. 2-{[(4-Cyclohexylthio-3-methyl-2-ρyridinyl)methyljthio)-5-(2,2,2-tri- fluorethoxy)-lH-benzimidazol102. 2 - {[(4-Cyclohexylthio-3-methyl-2-ρyridinyl) methyljthio) -5- (2,2,2-tri-fluoroethoxy) -IH-benzimidazole
103. 2-{[(4-Allylthio-3-methyl-2-pyridinylJmethyljthio}-5-(2,2,2-trifluor¬ ethoxy)-lH-benzimidazol103. 2 - {[(4-Allylthio-3-methyl-2-pyridinyl-methylmthio} -5- (2,2,2-trifluoroethoxy) -IH-benzimidazole
104. 2-([(3-Methyl-4-(2-methyl-allylthio)-2-pyridinyl)methyljthio}-5- (2,2,2-trifluorethoxy)-lH-benzimidazol und ihre Salze.104. 2 - ([(3-Methyl-4- (2-methyl-allylthio) -2-pyridinyl) methyljthio} -5- (2,2,2-trifluoroethoxy) -lH-benzimidazole and its salts.
Gegenstand der Erfindung sind innerhalb der Ausgestaltung d solche neuenThe subject matter of the invention is such new ones within the embodiment d
Verbindungen der Formel I, worinCompounds of formula I, wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet,R3 means hydrogen,
R4 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,R4 denotes hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 Aryl-4-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 is aryl-4-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet und n die Zahl 0 oder 1 bedeutet, und ihre Salze.
Gegenstand der Erfindung sind innerhalb der Ausgestaltung d außerdem solche neuen Verbindungen der Formel I, worinR6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy and n is 0 or 1, and their salts. Within the scope of embodiment d, the invention also relates to those new compounds of the formula I in which
Rl Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet,R1 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet,R3 means hydrogen,
R4 Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet,R4 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 Aryl-2-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro, Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy oder Halogen bedeutet,R5 is aryl-2-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro, trifluoromethyl or trifluoromethoxy and R52 is hydrogen Is 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet und n die Zahl 0 oder 1 bedeutet, und ihre Salze.R6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy and n is the number 0 or 1, and their salts.
Gegenstand der Erfindung sind innerhalb der Ausgestaltung d weiterhin die folgenden neuen Verbindungen:Within the scope of embodiment d, the invention furthermore relates to the following new compounds:
105. 2-{[[3-Methyl-4-(2-ρhenylethylthio)-2-pyridinyljmethyl]thio)-lH-benz- i idazol, Schmp. 145-146βC105. 2 - {[[3-Methyl-4- (2-ρhenylethylthio) -2-pyridinyljmethyl] thio) -lH-benz-i idazole, mp 145-146 β C
106. 2-{[[3-Methyl-4-(3-phenylpropylthio)-2-pyridinyljmethyljthio)-lH-benz- imidazol, Schmp. 80-82"C106. 2 - {[[3-Methyl-4- (3-phenylpropylthio) -2-pyridinyljmethyljthio) -lH-benzimidazole, m.p. 80-82 "C
107. 5-Methoxy-2-{[[3-methyl-4-(3-phenylpropylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol , Schmp. 142-143βC107. 5-Methoxy-2 - {[[3-methyl-4- (3-phenylpropylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole, mp 142-143 β C
108. 2-{[[3-Methoxy-4-(2-phenylethylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol, Schmp. 179-180βC.108. 2 - {[[3-methoxy-4- (2-phenylethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole, m.p. 179-180 β C.
109. 2-{[[3-Methoxy-4-(3-phenylpropylthio)-2-pyridinyljmethyljthio}-lH- benzimidazol , Schmp. 103-105°C109. 2 - {[[3-methoxy-4- (3-phenylpropylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole, m.p. 103-105 ° C
110. 5-Methoxy-2-{[[3-methyl-4-(2-phenylethylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol110. 5-Methoxy-2 - {[[3-methyl-4- (2-phenylethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
111. 2-{[[3-Methyl-4-(4-phenylbutylthio)-2-pyridinyljmethyljthio}-lH-benz- i idazol111. 2 - {[[3-Methyl-4- (4-phenylbutylthio) -2-pyridinyljmethyljthio} -lH-benz-i idazole
112. 2-{[[3-Methyl-4-(5-phenylpentylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol
113. 5-Methoxy-2-{[[3-methyl-4-(5-phenylpentylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol112. 2 - {[[3-Methyl-4- (5-phenylpentylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole 113. 5-Methoxy-2 - {[[3-methyl-4- (5-phenylpentylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
114. 2-{[[3-Methoxy-4-(4-phenylbutylthio)-2-pyridinyljmethyl]thio}-lH-benz- i idazol114. 2 - {[[3-methoxy-4- (4-phenylbutylthio) -2-pyridinyljmethyl] thio} -IH-benz-i idazole
115. 2-{[[3-Methoxy-4-(5-phenylpentylthio)-2-pyridinyljmethyljthio}-lH- benzimidazol115. 2 - {[[3-methoxy-4- (5-phenylpentylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
116. 5-Methoxy-2-{[[3-methyl-4-(4-phenylbutylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol116. 5-Methoxy-2 - {[[3-methyl-4- (4-phenylbutylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
117. 2-{[[3-Ethyl-4-(2-phenylethylthio)-2-pyridinyljmethyljthio}-lH-benz- i idazol117. 2 - {[[3-Ethyl-4- (2-phenylethylthio) -2-pyridinyljmethyljthio} -lH-benz-i idazole
118. 2-{[[3-Ethyl-4-(3-phenylpropylthio)-2-pyridinyljmethyljthio}-lH-benz- i idazol118.2 - {[[3-Ethyl-4- (3-phenylpropylthio) -2-pyridinyljmethyljthio} -lH-benz-i idazole
119. 2-{[[3-Ethyl-4-(4-phenylbutylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol119. 2 - {[[3-Ethyl-4- (4-phenylbutylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
120. 2-{[[3-Ethyl-4-(5-phenylpentylthio)-2-pyridinyljmethyl thio}-lH-benz- imidazol120. 2 - {[[3-Ethyl-4- (5-phenylpentylthio) -2-pyridinyljmethylthio} -lH-benzimidazole
121. 5-Methoxy-2-{[[3-ethyl-4-(2-phenylethylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol121. 5-Methoxy-2 - {[[3-ethyl-4- (2-phenylethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
122. 5-Methoxy-2-{[[3-ethyl-4-(3-phenylpropylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol122. 5-Methoxy-2 - {[[3-ethyl-4- (3-phenylpropylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
123. 5-Methoxy-2-{[[3-ethyl-4-(4-phenylbutylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol123. 5-Methoxy-2 - {[[3-ethyl-4- (4-phenylbutylthio) -2-pyridinyljmethylj-thio} -lH-benzimidazole
124. 5-Methoxy-2-{[[3-ethyl-4-(5-phenylpentylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol124. 5-Methoxy-2 - {[[3-ethyl-4- (5-phenylpentylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
125. 2-{[[3-Ethoxy-4-(2-phenylethylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol125. 2 - {[[3-Ethoxy-4- (2-phenylethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
126. 2-{[[3-Ethoxy-4-(3-phenylpropylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol126. 2 - {[[3-Ethoxy-4- (3-phenylpropylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
127. 2-{[[3-Ethoxy-4-(4-phenylbutylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol127. 2 - {[[3-Ethoxy-4- (4-phenylbutylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
128. 2-{[[3-Ethoxy-4-(5-phenylpentylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol128. 2 - {[[3-Ethoxy-4- (5-phenylpentylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
129. 2-{[[4-(2-Phenylethylthio)-2-pyridinyl]methyl]thio}-lH-benzimidazol (Schmp. des Dihydrochlorids 218-220"C, Zers.)129. 2 - {[[4- (2-phenylethylthio) -2-pyridinyl] methyl] thio} -lH-benzimidazole (mp of the dihydrochloride 218-220 "C, dec.)
130. 2-{[[4-(3-Phenylpropylthio)-2-pyridinyljmethyljthio}-lH-benzimidazol130. 2 - {[[4- (3-Phenylpropylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
131. 2-{[[4-(4-Phenylbutylthio)-2-pyridinyljmethyl]thio}-lH-benzimidazol131. 2 - {[[4- (4-Phenylbutylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
132. 2-{[[4-(5-Phenylpentylthio)-2-pyridinyljmethyljthio}-lH-benzimidazol
133. 2-{[[3,5-Dimethyl-4-(2-phenylethylthio)-2-pyridinyljmethyljthio}-1H- benzimidazol132. 2 - {[[4- (5-Phenylpentylthio) -2-pyridinyljmethyljthio} -IH-benzimidazole 133. 2 - {[[3,5-Dimethyl-4- (2-phenylethylthio) -2-pyridinyljmethyljthio} -1H-benzimidazole
134. 2-{[[3,5-Dimethyl-4-(3-phenylpropylthio)-2-pyridinyljmethyljthio}-1H- benzimidazol134. 2 - {[[3,5-Dimethyl-4- (3-phenylpropylthio) -2-pyridinyljmethyljthio} -1H-benzimidazole
135. 2-{[[3,5-Dimethyl-4-(4-phenylbutylthio)-2-pyridinyljmethyljthio}-lH- benzimidazol135. 2 - {[[3,5-Dimethyl-4- (4-phenylbutylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
136. 2-{[[3,5-Dimethyl-4-(5-phenylpentylthio)-2-pyridinyljmethyljthio}-1H- benzimidazol136. 2 - {[[3,5-Dimethyl-4- (5-phenylpentylthio) -2-pyridinyljmethyljthio} -1H-benzimidazole
137. 5-Methoxy-2-{[[4-(3-phenylpropylthio)-2-pyridinyljmethyl]-thio}-1H- benzimidazol137. 5-Methoxy-2 - {[[4- (3-phenylpropylthio) -2-pyridinyljmethyl] thio} -1H-benzimidazole
138. 5-Methoxy-2-{[[4-(2-phenylethylthio)-2-pyridinyljmethyl]-thio}-lH- benzimidazol138. 5-Methoxy-2 - {[[4- (2-phenylethylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
139. 5-Methoxy-2-{[[4-(5-phenylpentylthio)-2-pyridinyljmethyl]-thio}-1H- benzimidazol139. 5-Methoxy-2 - {[[4- (5-phenylpentylthio) -2-pyridinyljmethyl] thio} -1H-benzimidazole
140. 5-Methoxy-2-{[[4-(4-phenylbutylthio)-2-pyridinyljmethyl]-thio}-1H- benzimidazol140. 5-Methoxy-2 - {[[4- (4-phenylbutylthio) -2-pyridinyljmethyl] thio} -1H-benzimidazole
141. 5-Methoxy-2-{[[3,5-dimethyl-4-(3-phenylpropylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol141. 5-Methoxy-2 - {[[3,5-dimethyl-4- (3-phenylpropylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
142. 5-Methoxy-2-{[[3,5-dimethyl-4-(2-phenylethylthio)-2-pyridinyljmethyl] thio}-lH-benzimidazol142. 5-Methoxy-2 - {[[3,5-dimethyl-4- (2-phenylethylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
143. 5-Methoxy-2-{[[3,5-dimethyl-4-(5-phenylpentylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol143. 5-Methoxy-2 - {[[3,5-dimethyl-4- (5-phenylpentylthio) -2-pyridinylmethylthio} -lH-benzimidazole
144. 5-Methoxy-2-{[[3,5-dimethyl-4-(4-phenylbutylthio)-2-pyridinyljmethyl] thio}-lH-benzimidazol144. 5-Methoxy-2 - {[[3,5-dimethyl-4- (4-phenylbutylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
145. 5-Methoxy-2-{[[3-methoxy-4-(3-phenylpropy1thio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol145. 5-Methoxy-2 - {[[3-methoxy-4- (3-phenylpropy1thio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
146. 5-Methoxy-2-{[[3-methoxy-4-(2-phenylethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol146. 5-Methoxy-2 - {[[3-methoxy-4- (2-phenylethylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
147. 5-Methoxy-2-{[[3-methoxy-4-(5-phenylpentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol147. 5-Methoxy-2 - {[[3-methoxy-4- (5-phenylpentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
148. 5-Methoxy-2-{[[3-methoxy-4-(4-phenylbutylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol148. 5-Methoxy-2 - {[[3-methoxy-4- (4-phenylbutylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
149. 2-{[[3-Methyl-4-(2-(4-methylphenyl)ethylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol149. 2 - {[[3-Methyl-4- (2- (4-methylphenyl) ethylthio) -2-pyridinyljmethylj-thio} -lH-benzimidazole
150. 2-{[[3-Methyl-4-(3-(4-methylphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol
151. 5-Methoxy-2-{[[3-methyl-4-(3-(4-methylphenyl)propylthio)-2-pyridinyl]■ methyl]thio}-lH-benzimidazol150. 2 - {[[3-Methyl-4- (3- (4-methylphenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole 151. 5-Methoxy-2 - {[[3-methyl-4- (3- (4-methylphenyl) propylthio) -2-pyridinyl] ■ methyl] thio} -IH-benzimidazole
152. 2-{[[3-Methoxy-4-(2-(4-methylphenyl)ethylthio)-2-pyridinyl]methyl]- thio}-lH-benzimidazol152. 2 - {[[3-methoxy-4- (2- (4-methylphenyl) ethylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
153. 2-{[[3-Methoxy-4-(3-(4-methylphenyl)propylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol153. 2 - {[[3-Methoxy-4- (3- (4-methylphenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
154. 5-Methoxy-2-{[[3-methyl-4-(2-(4-methylphenyl)ethylthio)-2-pyridinyl]- methyljthio}-lH-benzimidazol154. 5-Methoxy-2 - {[[3-methyl-4- (2- (4-methylphenyl) ethylthio) -2-pyridinyl] methyljthio} -IH-benzimidazole
155. 2-{[[3-Methyl-4-(4-(4-methylphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol155. 2 - {[[3-Methyl-4- (4- (4-methylphenyl) butylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
156. 2-{[[3-Methyl-4-(5-(4-methylphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol156. 2 - {[[3-Methyl-4- (5- (4-methylphenyl) pentylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
157. 5-Methoxy-2-{[[3-methyl-4-(5-(4-methylphenylJpentylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol157. 5-Methoxy-2 - {[[3-methyl-4- (5- (4-methylphenylpentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
158. 2-{[[3-Methoxy-4-(4-(4-methylphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol158. 2 - {[[3-methoxy-4- (4- (4-methylphenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
159. 2-{[[3-Methoxy-4-(5-(4-methylphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol159. 2 - {[[3-methoxy-4- (5- (4-methylphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
160. 5-Methoxy-2-{[[3-methyl-4-(4-(4-methylphenyl)butylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol160. 5-Methoxy-2 - {[[3-methyl-4- (4- (4-methylphenyl) butylthio) -2-pyridinylj-methyl] thio} -IH-benzimidazole
161. 2-{[[3-Ethyl-4-(2-(4-methylphenyl)ethylthio)-2-pyridinyljmethyljthio}- IH-benzimidazol161. 2 - {[[3-Ethyl-4- (2- (4-methylphenyl) ethylthio) -2-pyridinyljmethyljthio} - IH-benzimidazole
162. 2-{[[3-Ethyl-4-(3-(4-methylphenyl )propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol162. 2 - {[[3-Ethyl-4- (3- (4-methylphenyl) propylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
163. 2-{[[3-Ethyl-4-(4-(4-methylphenyl)butylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol163. 2 - {[[3-Ethyl-4- (4- (4-methylphenyl) butylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
164. 2-{[[3-Ethyl-4-(5-(4-methylphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol164. 2 - {[[3-Ethyl-4- (5- (4-methylphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
165. 5-Methoxy-2-{[[3-ethyl-4-(2-(4-methylphenyl)ethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol165. 5-Methoxy-2 - {[[3-ethyl-4- (2- (4-methylphenyl) ethylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
166. 5-Methoxy-2-{[[3-ethyl-4-(3-(4-methylphenyl)propylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol166. 5-Methoxy-2 - {[[3-ethyl-4- (3- (4-methylphenyl) propylthio) -2-pyridinylj-methyl] thio} -IH-benzimidazole
167. 5-Methoxy-2-{[[3-ethyl-4-(4-(4-methylphenyl)butylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol167. 5-Methoxy-2 - {[[3-ethyl-4- (4- (4-methylphenyl) butylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
168. 5-Methoxy-2-{[[3-ethyl-4-(5-(4-methylphenyl)pentylthio)-2-pyridinylj- methyljthio}-lH-benzimidazol
169. 2-{[[3-Ethoxy-4-(2-(4-methylphenyl)ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol168. 5-Methoxy-2 - {[[3-ethyl-4- (5- (4-methylphenyl) pentylthio) -2-pyridinylj-methyljthio} -lH-benzimidazole 169. 2 - {[[3-Ethoxy-4- (2- (4-methylphenyl) ethylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
170. 2-{[[3-Ethoxy-4-(3-(4-methylphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol170. 2 - {[[3-Ethoxy-4- (3- (4-methylphenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
171. 2-{[[3-Ethoxy-4-(4-(4-methylpheny1)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol171. 2 - {[[3-Ethoxy-4- (4- (4-methylpheny1) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
172. 2-{[[3-Ethoxy-4-(5-(4-methylphenyl)pentylthio)-2-pyridinyljmethylj- thio)-lH-benzimidazol172. 2 - {[[3-Ethoxy-4- (5- (4-methylphenyl) pentylthio) -2-pyridinyljmethyljthio) -IH-benzimidazole
173. 2-{[[4-(2-(4-methylphenyl)ethylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol173. 2 - {[[4- (2- (4-methylphenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
174. 2-{[[4-(3-(4-methylphenyl)propylthio)-2-pyridinyljmethyl]thio}-lH- benzimidazol174. 2 - {[[4- (3- (4-methylphenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
175. 2-{[[4-(4-(4-methylphenylJbutylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol175. 2 - {[[4- (4- (4-methylphenylJbutylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
176. 2-{[[4-(5-(4-methylphenylJpentylthioJ-2-pyridinyljmethyl]thio)-lH- benzimidazol176. 2 - {[[4- (5- (4-MethylphenylJpentylthioJ-2-pyridinyljmethyl] thio) -IH-benzimidazole
177. 2-{[[3,5-Dimethyl-4-(2-(4-methylphenylJethylthioJ-2-pyridinyljmethyl]- thio}-lH-benzimidazol177. 2 - {[[3,5-Dimethyl-4- (2- (4-methylphenylethylthioJ-2-pyridinyljmethyl] thio} -IH-benzimidazole
178. 2-{[[3,5-Dimethyl-4-(3-(4-methylphenylJpropylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol178. 2 - {[[3,5-Dimethyl-4- (3- (4-methylphenylpropylthio) -2-pyridinylmethylthio} -lH-benzimidazole
179. 2-{[[3,5-Dimethyl-4-(4-(4-methylphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol179. 2 - {[[3,5-Dimethyl-4- (4- (4-methylphenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
180. 2-{[[3,5-Dimethyl-4-(5-(4-methylphenyl)pentylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol180. 2 - {[[3,5-Dimethyl-4- (5- (4-methylphenyl) pentylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
181. 5-Methoxy-2-{[[4-(3-(4-methylphenyl)propylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol181. 5-Methoxy-2 - {[[4- (3- (4-methylphenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
182. 5-Methoxy-2-{[[4-(2-(4-methylphenyl)ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol182. 5-Methoxy-2 - {[[4- (2- (4-methylphenyl) ethylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
183. 5-Methoxy-2-{[[4-(5-(4-methylphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol183. 5-Methoxy-2 - {[[4- (5- (4-methylphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
184. 5-Methoxy-2-{[[4-(4-(4-methylphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol184. 5-Methoxy-2 - {[[4- (4- (4-methylphenyl) butylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
185. 5-Methoxy-2-{[[3,5-dimethyl-4-(3-(4-methylphenyl)propylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol185. 5-Methoxy-2 - {[[3,5-dimethyl-4- (3- (4-methylphenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
186. 5-Methoxy-2-{[[3,5-dimethyl-4-(2-(4-methylphenylJethylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol
187. 5-Methoxy-2-{[[3,5-dimethyl-4-(5-(4-methylphenyl)pentylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol186. 5-Methoxy-2 - {[[3,5-dimethyl-4- (2- (4-methylphenylethylthio) -2-pyridinylylmethylthio} -lH-benzimidazole 187. 5-Methoxy-2 - {[[3,5-dimethyl-4- (5- (4-methylphenyl) pentylthio) -2-pyridynyljmethyljthio} -lH-benzimidazole
188. 5-Methoxy-2-{[[3,5-dimethyl-4-(4-(4-methylphenyl)butylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol188. 5-Methoxy-2 - {[[3,5-dimethyl-4- (4- (4-methylphenyl) butylthio) -2-pyridinylylmethyl] thio} -lH-benzimidazole
189. 5-Methoxy-2-{[[3-methoxy-4-(3-(4-methylphenyl)propylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol189. 5-Methoxy-2 - {[[3-methoxy-4- (3- (4-methylphenyl) propylthio) -2-pyridynylmethyljthio} -lH-benzimidazole
190. 5-Methoxy-2-{[[3-methoxy-4-(2-(4-methylphenyl)ethylthio)-2-pyridinyl]■ methyl]thio}-lH-benzimidazol190. 5-Methoxy-2 - {[[3-methoxy-4- (2- (4-methylphenyl) ethylthio) -2-pyridinyl] ■ methyl] thio} -IH-benzimidazole
191. 5-Methoxy-2-{[[3-methoxy-4-(5-(4-methylphenyl)pentylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol191. 5-Methoxy-2 - {[[3-methoxy-4- (5- (4-methylphenyl) pentylthio) -2-pyridynyljmethyljthio} -lH-benzimidazole
192. 5-Methoxy-2-{[[3-methoxy-4-(4-(4-methylphenyl)butylthio)-2-pyridinylj- methyljthio}-lH-benzimidazol192. 5-Methoxy-2 - {[[3-methoxy-4- (4- (4-methylphenyl) butylthio) -2-pyridinylj-methyljthio} -lH-benzimidazole
193. 2-{[[3-Methyl-4-(2-(4-methoxyphenyl)ethylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol193. 2 - {[[3-Methyl-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
194. 2-{[[3-Methyl-4-(3-(4-methoxyphenyl)propylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol194. 2 - {[[3-Methyl-4- (3- (4-methoxyphenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
195. 5-Methoxy-2-{[[3-methyl-4-(3-(4-methoxyphenyl)propylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol195. 5-Methoxy-2 - {[[3-methyl-4- (3- (4-methoxyphenyl) propylthio) -2-pyridynyljmethyljthio} -lH-benzimidazole
196. 2-{[[3-Methoxy-4-(2-(4-methoxyphenyl)ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol196. 2 - {[[3-methoxy-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
197. 2-{[[3-Methoxy-4-(3-(4-methoxyphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol197. 2 - {[[3-methoxy-4- (3- (4-methoxyphenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
198. 5-Methoxy-2-{[[3-methyl-4-(2-(4-methoxyphenyl)ethylthio)-2-pyridinyl]- methyl]thio}-lH-benzimidazol198. 5-Methoxy-2 - {[[3-methyl-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
199. 2-{[[3-Methyl-4-(4-(4-methoxyphenyl)butylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol199. 2 - {[[3-Methyl-4- (4- (4-methoxyphenyl) butylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
200. 2-{[[3-Methyl-4-(5-(4-methoxyphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol200. 2 - {[[3-Methyl-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
201. 5-Methoxy-2-{[[3-methyl-4-(5-(4-methoxyphenyl)pentylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol201. 5-Methoxy-2 - {[[3-methyl-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinylylmethyl] thio} -lH-benzimidazole
202. 2-{[[3-Methoxy-4-(4-(4-methoxyphenyl)butylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol202. 2 - {[[3-methoxy-4- (4- (4-methoxyphenyl) butylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
203. 2-{[[3-Methoxy-4-(5-(4-methoxyphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol203. 2 - {[[3-methoxy-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
204. 5-Methoxy-2-{[[3-methyl-4-(4-(4-methoxyphenyl)butylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol
205. 2-{[[3-Ethyl-4-(2-(4-methoxyphenyl )ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol204. 5-Methoxy-2 - {[[3-methyl-4- (4- (4-methoxyphenyl) butylthio) -2-pyridinylj-methyl] thio} -lH-benzimidazole 205. 2 - {[[3-Ethyl-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
206. 2-{[[3-Ethyl-4-(3-(4-methoxyphenyl)propylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol206. 2 - {[[3-Ethyl-4- (3- (4-methoxyphenyl) propylthio) -2-pyridinyljmethylj-thio} -lH-benzimidazole
207. 2-{[[3-Ethyl-4-(4-(4-methoxyphenyl)butylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol207. 2 - {[[3-ethyl-4- (4- (4-methoxyphenyl) butylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
208. 2-{[[3-Ethyl-4-(5-(4-methoxyphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol208. 2 - {[[3-Ethyl-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
209. 5-Methoxy-2-{[[3-ethyl-4-(2-(4-methoxyphenyl)ethylthio)-2-pyridinylj- methyljthio}-lH-benzimidazol209. 5-Methoxy-2 - {[[3-ethyl-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinylj-methyljthio} -IH-benzimidazole
210. 5-Methoxy-2-{[[3-ethyl-4-(3-(4-methoxyphenyl)propylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol210. 5-Methoxy-2 - {[[3-ethyl-4- (3- (4-methoxyphenyl) propylthio) -2-pyridinylj-methyl] thio} -lH-benzimidazole
211. 5-Methoxy-2-{[[3-ethyl-4-(4-(4-methoxyphenyl)butylthioJ-2-pyridinylj- methyljthio}-lH-benzimidazol211. 5-Methoxy-2 - {[[3-ethyl-4- (4- (4-methoxyphenyl) butylthioJ-2-pyridinylj-methyljthio} -lH-benzimidazole
212. 5-Methoxy-2-{[[3-ethyl-4-(5-(4-methoxyphenyl)pentylthio)-2-pyridinylj- methyljthio}-lH-benzimidazol212. 5-Methoxy-2 - {[[3-ethyl-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinylj-methyljthio} -lH-benzimidazole
213. 2-{[[3-Ethoxy-4-(2-(4-methoxyphenyl)ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol213. 2 - {[[3-Ethoxy-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
214. 2-{[[3-Ethoxy-4-(3-(4-methoxyphenyl)propylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol214. 2 - {[[3-Ethoxy-4- (3- (4-methoxyphenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
215. 2-{[[3-Ethoxy-4-(4-(4-methoxyphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol215. 2 - {[[3-Ethoxy-4- (4- (4-methoxyphenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
216. 2-{[[3-Ethoxy-4-(5-(4-methoxyphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol216. 2 - {[[3-Ethoxy-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
217. 2-{[[4-(2-(4-methoxyphenyl)ethylthio)-2-pyridinyljmethyljthio}-lH- benzimidazol217. 2 - {[[4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
218. 2-{[[4-(3-(4-methoxyphenyl)propylthio)-2-pyridinyljmethyljthio}-1H- benzimidazol218. 2 - {[[4- (3- (4-methoxyphenyl) propylthio) -2-pyridinyljmethyljthio} -1H-benzimidazole
219. 2-{[[4-(4-(4-methoxyphenyl)butylthio)-2-pyridinyljmethyljthio}-1H- benzimidazol219. 2 - {[[4- (4- (4-methoxyphenyl) butylthio) -2-pyridinyljmethyljthio} -1H-benzimidazole
220. 2-{[[4-(5-(4-methoxyphenyl)pentylthio)-2-pyridinyljmethyljthio}-lH- benzimidazol220. 2 - {[[4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
221. 2-{[[3,5-Dimethyl-4-(2-(4-methoxyphenyl)ethylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol221. 2 - {[[3,5-Dimethyl-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinyljme¬ ethyljthio} -lH-benzimidazole
222. 2-{[[3,5-Dimethyl-4-(3-(4-methoxyphenyl)propylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol
223. 2-{[[3,5-Dimethyl-4-(4-(4-methoxyphenyl)butylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol222. 2 - {[[3,5-Dimethyl-4- (3- (4-methoxyphenyl) propylthio) -2-pyridinylmethylthio} -lH-benzimidazole 223. 2 - {[[3,5-Dimethyl-4- (4- (4-methoxyphenyl) butylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
224. 2-{[[3,5-Dimethyl-4-(5-(4-methoxyphenyl)pentylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol224. 2 - {[[3,5-Dimethyl-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinyl-methyl] thio} -IH-benzimidazole
225. 5-Methoxy-2-{[[4-(3-(4-methoxyphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol225. 5-Methoxy-2 - {[[4- (3- (4-methoxyphenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
226. 5-Methoxy-2-{[[4-(2-(4-methoxyphenyl)ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol226. 5-Methoxy-2 - {[[4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
227. 5-Methoxy-2-{[[4-(5-(4-methoxyphenyl)pentylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol227. 5-Methoxy-2 - {[[4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
228. 5-Methoxy-2-{[[4-(4-(4-methoxyphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol228. 5-Methoxy-2 - {[[4- (4- (4-methoxyphenyl) butylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
229. 5-Methoxy-2-{[[3,5-dimethyl-4-(3-(4-methoxyphenyl )propylthio)-2-pyri- dinyljme-thyl]thio}-lH-benzimidazol229. 5-Methoxy-2 - {[[3,5-dimethyl-4- (3- (4-methoxyphenyl) propylthio) -2-pyridinylaminomethyl] thio} -IH-benzimidazole
230. 5-Methoxy-2-{[[3,5-dimethyl-4-(2-(4-methoxyphenyl)ethylthio)-2-pyridi nyljmethyljthio}-lH-benzimidazol230. 5-Methoxy-2 - {[[3,5-dimethyl-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridynylmethyljthio} -lH-benzimidazole
231. 5-Methoxy-2-{[[3,5-dimethyl-4-(5-(4-methoxyphenyl)pentylthio)-2-pyri- dinyljme-thyljthio}-lH-benzimidazol231. 5-Methoxy-2 - {[[3,5-dimethyl-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinylinyl-methylthio} -IH-benzimidazole
232. 5-Methoxy-2-{[[3,5-dimethyl-4-(4-(4-methoxyphenyl)butylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol232. 5-Methoxy-2 - {[[3,5-dimethyl-4- (4- (4-methoxyphenyl) butylthio) -2-pyridinylylmethyl] thio} -lH-benzimidazole
233. 5-Methoxy-2-{[[3-methoxy-4-(3-(4-methoxyphenyl)propylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol233. 5-Methoxy-2 - {[[3-methoxy-4- (3- (4-methoxyphenyl) propylthio) -2-pyridynyljmethyljthio} -lH-benzimidazole
234. 5-Methoxy-2-{[[3-methoxy-4-(2-(4-methoxyphenyl)ethylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol234. 5-Methoxy-2 - {[[3-methoxy-4- (2- (4-methoxyphenyl) ethylthio) -2-pyridinylylmethyl] thio} -lH-benzimidazole
235. 5-Methoxy-2-{[[3-methoxy-4-(5-(4-methoxyphenyl)pentylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol235. 5-Methoxy-2 - {[[3-methoxy-4- (5- (4-methoxyphenyl) pentylthio) -2-pyridinylylmethylthio} -IH-benzimidazole
236. 5-Methoxy-2-{[[3-methoxy-4-(4-(4-methoxyphenyl)butylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol236. 5-Methoxy-2 - {[[3-methoxy-4- (4- (4-methoxyphenyl) butylthio) -2-pyridynylmethyl] thio} -IH-benzimidazole
237. 2-{[[3-Methyl-4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol237. 2 - {[[3-Methyl-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
238. 2-{[[3-Methyl-4-(3-(4-fluorphenyl)propylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol238. 2 - {[[3-Methyl-4- (3- (4-fluorophenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
239. 5-Methoxy-2-{[[3-methyl-4-(3-(4-fluorphenyl)propylthio)-2-pyridinyl]- methyl]thio}-lH-benzimidazol239. 5-Methoxy-2 - {[[3-methyl-4- (3- (4-fluorophenyl) propylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
240. 2-{[[3-Methoxy-4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol
241. 2-{[[3-Methoxy-4-(3-(4-fluorphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol240. 2 - {[[3-methoxy-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole 241. 2 - {[[3-methoxy-4- (3- (4-fluorophenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
242. 5-Methoxy-2-{[[3-methyl-4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol242. 5-Methoxy-2 - {[[3-methyl-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
243. 2-{[[3-Methyl-4-(4-(4-fluorphenyl)butylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol243. 2 - {[[3-Methyl-4- (4- (4-fluorophenyl) butylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
244. Z- [[3-Methyl-4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol244. Z- [[3-Methyl-4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
245. 5-Methoxy-2-{[[3-methyl-4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyl]- methyl]thio}-lH-benzimidazol245. 5-Methoxy-2 - {[[3-methyl-4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
246. 2-{[[3-Methoxy-4-(4-(4-fluorphenyl)butylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol246. 2 - {[[3-methoxy-4- (4- (4-fluorophenyl) butylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
247. 2-{[[3-Methoxy-4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyl jmethyl]- thio}-lH-benzimidazol247. 2 - {[[3-methoxy-4- (5- (4-fluorophenyl) pentylthio) -2-pyridinylmethyl] thio} -IH-benzimidazole
248. 5-Methoxy-2-{[[3-methyl-4-(4-( -fluorphenyl)butylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol248. 5-Methoxy-2 - {[[3-methyl-4- (4- (-fluorophenyl) butylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
249. 2-{[[3-Ethyl-4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol249. 2 - {[[3-Ethyl-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
250. 2-{[[3-Ethyl-4-(3-(4-fluorphenyl)propylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol250. 2 - {[[3-Ethyl-4- (3- (4-fluorophenyl) propylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
251. 2-{[[3-Ethyl-4-(4-(4-fluorphenyl)butylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol251. 2 - {[[3-Ethyl-4- (4- (4-fluorophenyl) butylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
252. 2-{[[3-Ethyl-4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol252. 2 - {[[3-ethyl-4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
253. 5-Methoxy-2-{[[3-ethyl-4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol253. 5-Methoxy-2 - {[[3-ethyl-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
254. 5-Methoxy-2-{[[3-ethyl-4-(3-(4-fluorphenyl)propylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol254. 5-Methoxy-2 - {[[3-ethyl-4- (3- (4-fluorophenyl) propylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
255. 5-Methoxy-2-{[[3-ethyl-4-(4-(4-fluorphenyl)butylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol255. 5-Methoxy-2 - {[[3-ethyl-4- (4- (4-fluorophenyl) butylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
256. 5-Methoxy-2-{[[3-ethyl-4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol256. 5-Methoxy-2 - {[[3-ethyl-4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
257. 2-{[[3-Ethoxy-4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol257. 2 - {[[3-Ethoxy-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
258. 2-{[[3-Ethoxy-4-(3-(4-fluorphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol
259. 2-{[[3-Ethoxy-4-(4-(4-fluorphenyl)butylthio)-2-pyridinyljmethyljthio)■ lH-benzimidazol258. 2 - {[[3-Ethoxy-4- (3- (4-fluorophenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole 259. 2 - {[[3-ethoxy-4- (4- (4-fluorophenyl) butylthio) -2-pyridinyljmethyljthio) ■ 1H-benzimidazole
260. 2-{[[3-Ethoxy-4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol260. 2 - {[[3-Ethoxy-4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyljmethyljthio} -IH-benzimidazole
261. 2-{[[4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol261. 2 - {[[4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
262. 2-{[[4-(3-(4-fluorphenyl)propylthio)-2-pyridinyljmethyljthio}-lH-benz- i idazol262. 2 - {[[4- (3- (4-fluorophenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benz-i idazole
263. 2-{[[4-(4-(4-fluorphenyl)butylthio)-2-pyridinyljmethyl]thio}-IH-benz- imidazol263. 2 - {[[4- (4- (4-fluorophenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
264. 2-{[[4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyljmethyljthio)-lH-benz- imidazol264. 2 - {[[4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyljmethyljthio) -IH-benzimidazole
265. 2-{[[3,5-Dimethyl-4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljmethyl- thio}-lH-benzimidazol265. 2 - {[[3,5-Dimethyl-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyljmethylthio} -lH-benzimidazole
266. 2-{[[3,5-Dimethyl-4-(3-(4-fluorphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol266. 2 - {[[3,5-Dimethyl-4- (3- (4-fluorophenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
267. 2-{[[3,5-Dimethyl-4-(4-(4-fluorphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol267. 2 - {[[3,5-Dimethyl-4- (4- (4-fluorophenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
268. 2-{[[3,5-Dimethyl-4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol268. 2 - {[[3,5-Dimethyl-4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
269. 5-Methoxy-2-{[[4-(3-(4-fluorphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol269. 5-Methoxy-2 - {[[4- (3- (4-fluorophenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
270. 5-Methoxy-2-{[[4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol270. 5-Methoxy-2 - {[[4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
271. 5-Methoxy-2-{[[4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol271. 5-Methoxy-2 - {[[4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
272. 5-Methoxy-2-{[[4-(4-(4-fluorphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol272. 5-Methoxy-2 - {[[4- (4- (4-fluorophenyl) butylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
273. 5-Methoxy-2-{[[3,5-dimethyl-4-(3-(4-fluorphenyl)propylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol273. 5-Methoxy-2 - {[[3,5-dimethyl-4- (3- (4-fluorophenyl) propylthio) -2-pyridynyljmethyljthio} -lH-benzimidazole
274. 5-Methoxy-2-{[[3,5-dimethyl-4-(2-(4-fluorphenyl)ethylthio)-2-pyridi- nyl]methyl]thio}-lH-benzimidazol274. 5-Methoxy-2 - {[[3,5-dimethyl-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyl] methyl] thio} -lH-benzimidazole
275. 5-Methoxy-2-{[[3,5-dimethyl-4-(5-(4-fluorphenyl)pentylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol275. 5-Methoxy-2 - {[[3,5-dimethyl-4- (5- (4-fluorophenyl) pentylthio) -2-pyridynylmethyl] thio} -IH-benzimidazole
276. 5-Methoxy-2-{[[3,5-dimethyl-4-(4-(4-fluorphenyl)butylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol
277. 5-Methoxy-2-{[[3-methoxy-4-(3-(4-fluorphenyl)propylthio)-2-pyridinyl]■ methyl]thio}-lH-benzimidazol276. 5-Methoxy-2 - {[[3,5-dimethyl-4- (4- (4-fluorophenyl) butylthio) -2-pyridinylylmethyl] thio} -IH-benzimidazole 277. 5-Methoxy-2 - {[[3-methoxy-4- (3- (4-fluorophenyl) propylthio) -2-pyridinyl] ■ methyl] thio} -lH-benzimidazole
278. 5-Methoxy-2-{[[3-methoxy-4-(2-(4-fluorphenyl)ethylthio)-2-pyridinyl]- methyljthio}-lH-benzimidazol278. 5-Methoxy-2 - {[[3-methoxy-4- (2- (4-fluorophenyl) ethylthio) -2-pyridinyl] methyljthio} -IH-benzimidazole
279. 5-Methoxy-2-{[[3-methoxy-4-(5-(4-fluorphenyl)pentylthio)-2-pyridinyl]- methyl]thio}-lH-benzimidazol279. 5-Methoxy-2 - {[[3-methoxy-4- (5- (4-fluorophenyl) pentylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
280. 5-Methoxy-2-{[[3-methoxy-4-(4-(4-fluorphenyl)butylthio)-2-pyridinyl]- methyl]thio}-lH-benzimidazol280. 5-Methoxy-2 - {[[3-methoxy-4- (4- (4-fluorophenyl) butylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
281. 2-{[[3-Methyl-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol281. 2 - {[[3-Methyl-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
282. 2-{[[3-Methyl-4-(3-(2,4-difluorphenyl)propylthio)-2-pyridinyl]methyl]- thio}-lH-benzimidazol282. 2 - {[[3-methyl-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinyl] methyl] thio} -lH-benzimidazole
283. 5-Methoxy-2-{[[3-methyl-4-(3-(2,4-difluorphenyl)propylthio)-2-pyridi- nyl]methyl]-thio}-lH-benzimidazol283. 5-Methoxy-2 - {[[3-methyl-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
284. 2-{[[3-Methoxy-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol284. 2 - {[[3-methoxy-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
285. 2-{[[3-Methoxy-4-(3-(2,4-difluorphenyl)propylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol285. 2 - {[[3-methoxy-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinyljme¬ ethyljthio} -lH-benzimidazole
286. 5-Methoxy-2-{[[3-methyl-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridi- nyljmethylj-thio}-lH-benzimidazol286. 5-Methoxy-2 - {[[3-methyl-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridynyljmethylj-thio} -lH-benzimidazole
287. 2-{[[3-Methyl-4-(4-(2,4-difluorphenyl)butylthio)-2-pyridinyljmethyl]- thio)-lH-benzimidazol287. 2 - {[[3-methyl-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinyljmethyl] thio) -IH-benzimidazole
288. 2-{[[3-Methyl-4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridinyl]methylj- thio}-lH-benzimidazol288. 2 - {[[3-methyl-4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridinyl] methyljthio} -lH-benzimidazole
289. 5-Methoxy-2-{[[3-methyl-4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridi- nyljmethyl]-thio}-lH-benzimidazol289. 5-Methoxy-2 - {[[3-methyl-4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridynylmethyl] thio} -IH-benzimidazole
290. 2-{[[3-Methoxy-4-(4-(2,4-difluorphenyl )butylthio)-2-ρyridinyljmethyl]- thio}-lH-benzimidazol290. 2 - {[[3-methoxy-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
291. 2-{[[3-Methoxy-4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol291.2 - {[[3-methoxy-4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridinyl-methyl] thio} -IH-benzimidazole
292. 5-Methoxy-2-{[[3-methyl-4-(4-(2,4-difluorphenyl)butylthio)-2-pyridi- nyljmethylj-thio}-lH-benzimidazol292. 5-Methoxy-2 - {[[3-methyl-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridynyljmethylj-thio} -lH-benzimidazole
293. 2-{[[3-Ethyl-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol293. 2 - {[[3-ethyl-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyljmethylj-thio} -lH-benzimidazole
294. 2-{[[3-Ethyl-4-(3-(2,4-difluorphenyl)propylthio)-2-pyridinyl]methylj- thio}-lH-benzimidazol
295. 2-{[[3-Ethyl-4-(4-(2,4-difluorphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol294. 2 - {[[3-ethyl-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinyl] methyljthio} -lH-benzimidazole 295.2 - {[[3-Ethyl-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
296. 2-{[[3-Ethyl-4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridinyl]methyl]- thio}-lH-benzimidazol296. 2 - {[[3-ethyl-4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
297. 5-Methoxy-2-{[[3-ethyl-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridi- nyljmethylj-thio}-lH-benzimidazol297. 5-Methoxy-2 - {[[3-ethyl-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridynyljmethylj-thio} -lH-benzimidazole
298. 5-Methoxy-2-{[[3-ethyl-4-(3-(2,4-difluorphenyl)propylthio)-2-pyridi- nyljmethyl]-thio}-lH-benzimidazol298. 5-Methoxy-2 - {[[3-ethyl-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinylylmethyl] thio} -lH-benzimidazole
299. 5-Methoxy-2-{[[3-ethyl-4-(4-(2,4-difluorphenyl)butylthio)-2-pyridi- nyljmethyl]-thio}-lH-benzimidazol299. 5-Methoxy-2 - {[[3-ethyl-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinylylmethyl] thio} -IH-benzimidazole
300. 5-Methoxy-2-{[[3-ethyl-4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridi- nyljmethylj-thio}-lH-benzimidazol300. 5-Methoxy-2 - {[[3-ethyl-4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridynyljmethylj-thio} -lH-benzimidazole
301. 2-{[[3-Ethoxy-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol301. 2 - {[[3-Ethoxy-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
302. 2-{[[3-Ethoxy-4-(3-(2,4-difluorphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol302. 2 - {[[3-Ethoxy-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
303. 2-{[[3-Ethoxy-4-(4-(2,4-difluorphenyl)butylthio)-2-pyridinyl]methylj- thio}-lH-benzimidέzol303. 2 - {[[3-Ethoxy-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinyl] methylj-thio} -lH-benzimidέzole
304. 2-{[[3-Ethoxy-4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridinyl]methylj- thio}-lH-benzimidazol304. 2 - {[[3-Ethoxy-4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridinyl] methyljthio} -IH-benzimidazole
305. 2-{[[4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridinyljmethyl]thio}-lH- benzimidazol305. 2 - {[[4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
306. 2-{[[4-(3-(2,4-difluorphenyl)propylthio)-2-pyridinyl]methyl]thio}-lH- benzimidazol306. 2 - {[[4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
307. 2-{[[4-(4-(2,4-difluorphenyl)butylthio)-2-pyridinyl]methyl]thio}-lH- benzimidazol307. 2 - {[[4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
308. 2-{[[4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridinyl]methyl]thio}-lH- benzimidazol308. 2 - {[[4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
309. 2-{[[3,5-Dimethyl-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol309.2 - {[[3,5-Dimethyl-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyljme¬ ethyl] thio} -lH-benzimidazole
310. 2-{[[3,5-Dimethyl-4-(3-(2,4-difluorphenyl)propylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol310. 2 - {[[3,5-Dimethyl-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinyl-methyl] thio} -IH-benzimidazole
311. 2-{[[3,5-Dimethyl-4-(4-(2,4-difluorphenyl)butylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol311.2 - {[[3,5-Dimethyl-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinyljme¬ ethyl] thio} -lH-benzimidazole
312. 2-{[[3,5-Dimethyl-4-(5-(2, -difluorphenyl)pentylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol
313. 5-Methoxy-2-{[[4-(3-(2,4-difluorphenyl)propylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol312.2 - {[[3,5-dimethyl-4- (5- (2, -difluorophenyl) pentylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole 313. 5-Methoxy-2 - {[[4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinylmethylthio} -lH-benzimidazole
314. 5-Methoxy-2-{[[4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridinyl]methyl]- thio}-lH-benzimidazol314. 5-Methoxy-2 - {[[4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
315. 5-Methoxy-2-{[[4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol315. 5-Methoxy-2 - {[[4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
316. 5-Methoxy-2-{[[4-(4-(2,4-difluorphenyl)butylthio)-2-pyridinyl]methyl]- thio}-lH-benzimidazol316. 5-Methoxy-2 - {[[4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinyl] methyl] thio} -lH-benzimidazole
317. 5-Methoxy-2-{[[3,5-dimethyl-4-(3-(2,4-difluorphenyl)propylthio)-2-py- ridinyljme-thyljthio}-lH-benzimidazol317. 5-Methoxy-2 - {[[3,5-dimethyl-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridinyl-methyl-thio} -lH-benzimidazole
318. 5-Methoxy-2-{[[3,5-dimethyl-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyri- dinyljmethyl]thio}-lH-benzimidazol318. 5-Methoxy-2 - {[[3,5-dimethyl-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
319. 5-Methoxy-2-{[[3,5-dimethyl-4-(5-(2,4-difluorphenyl)pentylthio)-2-py- ridinyljme-thyljthio}-lH-benzimidazol319. 5-Methoxy-2 - {[[3,5-dimethyl-4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridinyl-methyl-thio} -lH-benzimidazole
320. 5-Methoxy-2-{[[3,5-dimethyl-4-(4-(2,4-difluorphenyl)butylthio)-2-pyri- dinyljmethyl]thio}-lH-benzimidazol320. 5-Methoxy-2 - {[[3,5-dimethyl-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
321. 5-Methoxy-2-{[[3-methoxy-4-(3-(2,4-difluorphenyl)propylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol321. 5-Methoxy-2 - {[[3-methoxy-4- (3- (2,4-difluorophenyl) propylthio) -2-pyridynylmethyl] thio} -IH-benzimidazole
322. 5-Methoxy-2-{[[3-methoxy-4-(2-(2,4-difluorphenyl)ethylthio)-2-pyridi- nyl]methyljthio}-lH-benzimidazol322. 5-Methoxy-2 - {[[3-methoxy-4- (2- (2,4-difluorophenyl) ethylthio) -2-pyridinyl] methyljthio} -lH-benzimidazole
323. 5-Methoxy-2-{[[3-methoxy-4-(5-(2,4-difluorphenyl)pentylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol323. 5-Methoxy-2 - {[[3-methoxy-4- (5- (2,4-difluorophenyl) pentylthio) -2-pyridinylylmethyl] thio} -IH-benzimidazole
324. 5-Methoxy-2-{[[3-methoxy-4-(4-(2,4-difluorphenyl)butylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol324. 5-Methoxy-2 - {[[3-methoxy-4- (4- (2,4-difluorophenyl) butylthio) -2-pyridinylylmethyl] thio} -IH-benzimidazole
325. 2-{[[3-Methyl-4-(2-(2-fluor-6-methylphenyl)ethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol325. 2 - {[[3-methyl-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinylmethyl] thio} -IH-benzimidazole
326. 2-{[[3-Methyl-4-(3-(2-fluor-6-methylphenyl )propylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol326. 2 - {[[3-Methyl-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
327. 5-Methoxy-2-{[[3-methyl-4-(3-(2-fluor-6-methylphenyl)propylthio)-2-py- ridinyljmethyl]thio}-lH-benzimidazol327. 5-Methoxy-2 - {[[3-methyl-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
328. 2-{[[3-Methoxy-4-(2-(2-fluor-6-methylphenyl)ethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol328. 2 - {[[3-methoxy-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
329. 2-{[[3-Methoxy-4-(3-(2-fluor-6-methylphenyl)propylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol329. 2 - {[[3-methoxy-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinylj-methyl] thio} -IH-benzimidazole
330. 5-Methoxy-2-{[[3-methyl-4-(2-(2-fluor-6-methylphenyl)ethylthio)-2-py- ridinyljmethyljthio}-lH-benzimidazol
331. 2-{[[3-Methyl-4-(4-(2-fluor-6-methylphenyl )butylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol330. 5-Methoxy-2 - {[[3-methyl-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole 331. 2 - {[[3-Methyl-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
332. 2-{[[3-Methyl-4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol332.2 - {[[3-Methyl-4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinyl-methyl] thio} -IH-benzimidazole
333. 5-Methoxy-2-{[[3-methyl-4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-py- ridinyljmethyl]thio}-lH-benzimidazol333. 5-Methoxy-2 - {[[3-methyl-4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
334. 2-{[[3-Methoxy-4-(4-(2-fluor-6-methylphenyl)butylthio)-2-pyridinyljme¬ thyl]thio)-lH-benzimidazol334. 2 - {[[3-methoxy-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinylmethyl] thio) -IH-benzimidazole
335. 2-{[[3-Methoxy-4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol335. 2 - {[[3-methoxy-4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinylj-methyl] thio} -IH-benzimidazole
336. 5-Methoxy-2-{[[3-methyl-4-(4-(2-fluor-6-methylphenyl)butylthio)-2-py- ridinyljmethyl]thio}-lH-benzimidazol336. 5-Methoxy-2 - {[[3-methyl-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
337. 2-{[[3-Ethyl-4-(2-(2-fluor-6-methylphenyl )ethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol337. 2 - {[[3-Ethyl-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinylmethyl] thio} -IH-benzimidazole
338. 2-{[[3-Ethyl-4-(3-(2-fluor-6-methylphenyl)propylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol338.2 - {[[3-Ethyl-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinylmethyl] thio} -lH-benzimidazole
339. 2-{[[3-Ethyl-4-(4-(2-fluor-6-methylphenyl)butylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol339. 2 - {[[3-ethyl-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
340. 2-{[[3-Ethyl-4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol340. 2 - {[[3-Ethyl-4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinyl-methyl] thio} -IH-benzimidazole
341. 5-Methoxy-2-{[[3-ethyl-4-(2-(2-fluor-6-methylphenyl)ethylthio)-2-pyri- dinyljmethyljthio}-lH-benzimidazol341. 5-Methoxy-2 - {[[3-ethyl-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
342. 5-Methoxy-2-{[[3-ethyl-4-(3-(2-fluor-6-methylphenyl )propylthio)-2-py- ridinyljmethyl]thio}-lH-benzimidazol342. 5-Methoxy-2 - {[[3-ethyl-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
343. 5-Methoxy-2-{[[3-ethyl-4-(4-(2-fluor-6-methylphenyl )butylthio)-2-py- ridinyljmethyljthio}-lH-benzimidazol343. 5-Methoxy-2 - {[[3-ethyl-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
344. 5-Methoxy-2-{[[3-ethyl-4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-py- ridinyljmethyljthio}-lH-benzimidazol344. 5-Methoxy-2 - {[[3-ethyl-4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinyljmethyljthio} -IH-benzimidazole
345. 2-{[[3-Ethoxy-4-(2-(2-fluor-6-methylphenyl)ethylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol345.2 - {[[3-Ethoxy-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
346. 2-{[[3-Ethoxy-4-(3-(2-fluor-6-methylphenyl)propylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol346. 2 - {[[3-Ethoxy-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinylmethyl] thio} -lH-benzimidazole
347. 2-{[[3-Ethoxy-4-(4-(2-fluor-6-methylphenyl)butylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol347.2 - {[[3-Ethoxy-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
348. 2-{[[3-Ethoxy-4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol
349. 2-{[[4-(2-(2-fluor-6-methylphenyl)ethylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol348. 2 - {[[3-Ethoxy-4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole 349. 2 - {[[4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
350. 2-{[[4-(3-(2-fluor-6-methylphenyl)propylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol350. 2 - {[[4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
351. 2-{[[4-(4-(2-fluor-6-methylphenyl)butylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol351. 2 - {[[4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
352. 2-{[[4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol352. 2 - {[[4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
353. 2-{[[3,5-Dimethyl-4-(2-(2-fluor-6-methylphenyl)ethy1thio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol353. 2 - {[[3,5-Dimethyl-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinylmethyljthio} -lH-benzimidazole
354. 2-{[[3,5-Dimethyl-4-(3-(2-fluor-6-methylphenyl)propylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol354. 2 - {[[3,5-Dimethyl-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinylmethyljthio} -lH-benzimidazole
355. 2-{[[3,5-Dimethyl-4-(4-(2-fluor-6-methylphenyl)butylthio)-2-pyridi- nyljmethyljthio}-lH-benzimidazol355. 2 - {[[3,5-Dimethyl-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridynylmethyljthio} -lH-benzimidazole
356. 2-{[[3,5-Dimethyl-4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-pyridi- nyl]methyl]thio}-lH-benzimidazol356. 2 - {[[3,5-Dimethyl-4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
357. 5-Methoxy-2-{[[4-(3-(2-fluor-6-methylphenyl)propylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol357. 5-Methoxy-2 - {[[4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinylj-methyl] thio} -lH-benzimidazole
358. 5-Methoxy-2-{[[4-(2-(2-fluor-6-methylphenyl)ethylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol358. 5-Methoxy-2 - {[[4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
359. 5-Methoxy-2-{[[4-(5-(2-fluor-6-methylphenyl)pentylthio)-2-pyridinylj- methyljthio}-lH-benzimidazol359. 5-Methoxy-2 - {[[4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinylj-methyljthio} -lH-benzimidazole
360. 5-Methoxy-2-{[[4-(4-(2-fluor-6-methylphenyl)butylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol360. 5-Methoxy-2 - {[[4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
361. 5-Methoxy-2-{[[3,5-dimethyl-4-(3-(2-fluor-6-methylphenyl)propylthio)- 2-pyridinyljme-thyl]thio}-lH-benzimidazol361. 5-Methoxy-2 - {[[3,5-dimethyl-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinyl-methyl] thio} -IH-benzimidazole
362. 5-Methoxy-2-{[[3,5-dimethyl-4-(2-(2-fluor-6-methylphenyl)ethylthio)-2- pyridinyljmethyljthio}-lH-benzimidazol362. 5-Methoxy-2 - {[[3,5-dimethyl-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
363. 5-Methoxy-2-{[[3,5-dimethyl-4-(5-(2-fluor-6-methylphenyl)pentylthio)- 2-pyridinyljme-thyl]thio}-lH-benzimidazol363. 5-Methoxy-2 - {[[3,5-dimethyl-4- (5- (2-fluoro-6-methylphenyl) pentylthio) - 2-pyridinyl-methyl] thio} -lH-benzimidazole
364. 5-Methoxy-2-{[[3,5-dimethyl-4-(4-(2-fluor-6-methylphenyl)butylthio)-2- pyridinyljmethyl]thio}-lH-benzimidazol364. 5-Methoxy-2 - {[[3,5-dimethyl-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
365. 5-Methoxy-2-{[[3-methoxy-4-(3-(2-fluor-6-methylphenyl)propylthio)-2- pyridinyljmethyljthio}-lH-benzimidazol365. 5-Methoxy-2 - {[[3-methoxy-4- (3- (2-fluoro-6-methylphenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
366. 5-Methoxy-2-{[[3-methoxy-4-(2-(2-fluor-6-methylphenyl )ethylthio)-2-py- ridinyljmethyl]thio}-lH-benzimidazol
367. 5-Methoxy-2-{[[3-methoxy-4-(5-(2-fluor-6-methylphenyl)pentylthio)-2- pyridinyljmethyljthio}-lH-benzimidazol366. 5-Methoxy-2 - {[[3-methoxy-4- (2- (2-fluoro-6-methylphenyl) ethylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole 367. 5-Methoxy-2 - {[[3-methoxy-4- (5- (2-fluoro-6-methylphenyl) pentylthio) -2-pyridinyljmethyljthio} -IH-benzimidazole
368. 5-Methoxy-2-{[[3-methoxy-4-(4-(2-fluor-6-methylphenyl)butylthio)-2-py- ridinyljmethyl]thio}-lH-benzimidazol368. 5-Methoxy-2 - {[[3-methoxy-4- (4- (2-fluoro-6-methylphenyl) butylthio) -2-pyridinylmethyl] thio} -IH-benzimidazole
369. 2-{[[3-Methyl-4-(2-(4-chlorphenyl)ethylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol369. 2 - {[[3-Methyl-4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
370. 2-{[[3-Methyl-4-(3-(4-chlorphenyl)propylthio)-2-pyridinyljmethylj- thio}-lH-benzimidazol370. 2 - {[[3-Methyl-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
371. 5-Methoxy-2-{[[3-methyl-4-(3-(4-chlorphenyl)propylthio)-2-pyridinyl]- methyl]thio}-lH-benzimidazol371. 5-Methoxy-2 - {[[3-methyl-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
372. 2-{[[3-Methoxy-4-(2-(4-chlorphenyl)ethylthio)-2-pyridinyl]methylj- thio}-lH-benzimidazol372. 2 - {[[3-methoxy-4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyl] methyljthio} -lH-benzimidazole
373. 2-{[[3-Methoxy-4-(3-(4-chlorphenyl)propylthio)-2-pyridinyl]methylj- thio}-lH-benzimidazol373. 2 - {[[3-methoxy-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyl] methyljthio} -lH-benzimidazole
374. 5-Methoxy-2-{[[3-methyl-4-(2-(4-chlorphenyl)ethylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol374. 5-Methoxy-2 - {[[3-methyl-4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
375. 2-{[[3-Methyl-4-(4-(4-chlorphenyl)butylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol375. 2 - {[[3-Methyl-4- (4- (4-chlorophenyl) butylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
376. 2-{[[3-Methyl-4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyl]methylj- thio}-lH-benzimidazol376. 2 - {[[3-methyl-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyl] methylj-thio} -lH-benzimidazole
377. 5-Methoxy-2-{[[3-methyl-4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyl]- methyl]thio}-lH-benzimidazol377. 5-Methoxy-2 - {[[3-methyl-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyl] methyl] thio} -IH-benzimidazole
378. 2-{[[3-Methoxy-4-(4-(4-chlorphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol378. 2 - {[[3-methoxy-4- (4- (4-chlorophenyl) butylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
379. 2-{[[3-Methoxy-4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol379. 2 - {[[3-methoxy-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
380. 5-Methoxy-2-{[[3-methyl-4-(4-(4-chlorphenyl)butylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol380. 5-methoxy-2 - {[[3-methyl-4- (4- (4-chlorophenyl) butylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
381. 2-{[[3-Ethyl-4-(2-(4-chlorphenyl )ethylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol381. 2 - {[[3-ethyl-4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
382. 2-{[[3-Ethyl-4-(3-(4-chlorphenyl )propylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol382. 2 - {[[3-Ethyl-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
383. 2-{[[3-Ethyl-4-(4-(4-chlorphenyl )butylthio)-2-pyridinyljmethyljthio}- lH-benzi idazol383. 2 - {[[3-Ethyl-4- (4- (4-chlorophenyl) butylthio) -2-pyridinyljmethyljthio} - 1H-benzi idazole
384. 2-{[[3-Ethyl-4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyljmethyljthio}- lH-benzi idazol
385. 5-Methoxy-2-{[[3-ethyl-4-(2-(4-chlorphenyl )ethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol384. 2 - {[[3-Ethyl-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyljmethyljthio} - 1H-benzi idazole 385. 5-Methoxy-2 - {[[3-ethyl-4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
386. 5-Methoxy-2-{[[3-ethyl-4-(3-(4-chlorphenyl)propylthio)-2-pyridinyljme¬ thyljthio}-lH-benzimidazol386. 5-Methoxy-2 - {[[3-ethyl-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyljme¬ thyljthio} -lH-benzimidazole
387. 5-Methoxy-2-{[[3-ethyl-4-(4-(4-chlorphenyl)butylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol387. 5-Methoxy-2 - {[[3-ethyl-4- (4- (4-chlorophenyl) butylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
388. 5-Methoxy-2-{[[3-ethyl-4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol388. 5-Methoxy-2 - {[[3-ethyl-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyl-methyl] thio} -lH-benzimidazole
389. 2-{[[3-Ethoxy-4-(2-(4-chlorphenyl)ethylthio)-2-pyridinyljmethyljthio}- lH-benzimidazol389. 2 - {[[3-Ethoxy-4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyljmethyljthio} - 1H-benzimidazole
390. 2-{[[3-Ethoxy-4-(3-(4-chlorphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol390. 2 - {[[3-Ethoxy-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
391. 2-{[[3-Ethoxy-4-(4-(4-chlorphenyl)butylthio)-2-ρyridinyljmethyljthio}- lH-benzimidazol391. 2 - {[[3-Ethoxy-4- (4- (4-chlorophenyl) butylthio) -2-ρyridinyljmethyljthio} - 1H-benzimidazole
392. 2-{[[3-Ethoxy-4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol392. 2 - {[[3-Ethoxy-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
393. 2-{[[4-(2-(4-chlorphenyl)ethylthio)-2-pyridinyljmethyl]thio}-lH-benz- i idazol393. 2 - {[[4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyljmethyl] thio} -lH-benz-i idazole
394. 2-{[[4-(3-(4-chlorphenyl)propylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol394. 2 - {[[4- (3- (4-chlorophenyl) propylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
395. 2-{[[4-(4-(4-chlorphenyl)butylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol395. 2 - {[[4- (4- (4-chlorophenyl) butylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
396. 2-{[[4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyljmethyljthio}-lH-benz- imidazol396. 2 - {[[4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyljmethyljthio} -lH-benzimidazole
397. 2-{[[3,5-Dimethyl-4-(2-(4-chlorphenyl)ethylthio)-2-pyridinyljmethyl]- thio)-lH-benzimidazol397. 2 - {[[3,5-Dimethyl-4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyljmethyl] thio) -IH-benzimidazole
398. 2-{[[3,5-Dimethyl-4-(3-(4-chlorphenyl)propylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol398. 2 - {[[3,5-Dimethyl-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
399. 2-{[[3,5-Dimethyl-4-(4-(4-chlorphenyl)butylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol399. 2 - {[[3,5-Dimethyl-4- (4- (4-chlorophenyl) butylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
400. 2-{[[3,5-Dimethyl-4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol400. 2 - {[[3,5-Dimethyl-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyljmethyl] thio} -IH-benzimidazole
401. 5-Methoxy-2-{[[4-(3-(4-chlorphenyl)propylthio)-2-pyridinyljmethyl]- thio)-lH-benzimidazol401. 5-Methoxy-2 - {[[4- (3- (4-chlorophenyl) propylthio) -2-pyridinyljmethyl] thio) -IH-benzimidazole
402. 5-Methoxy-2-{[[4-(2-(4-chlorphenyl )ethylthio)-2-pyridinyljmethyl]- thio}-lH-benzimidazol
403. 5-Methoxy-2-{[[4-(5-(4-chlorphenyl)pentylthio)-2-pyridinyljmethyl ]- thio}-lH-benzimidazol402. 5-Methoxy-2 - {[[4- (2- (4-chlorophenyl) ethylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole 403. 5-Methoxy-2 - {[[4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyljmethyl] thio} -lH-benzimidazole
404. 5-Methoxy-2-{[[4-(4-(4-chlorphenyl)butylthio)-2-pyridinyl jmethyl]- thio}-lH-benzimidazol404. 5-Methoxy-2 - {[[4- (4- (4-chlorophenyl) butylthio) -2-pyridinylmethyl] thio} -lH-benzimidazole
405. 5-Methoxy-2-{[[3,5-dimethyl-4-(3-(4-chlorphenyl)propylthio)-2-pyridi- nyl jme-thyl]thio}-lH-benzimidazol405. 5-Methoxy-2 - {[[3,5-dimethyl-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyl nimethyl] thio} -IH-benzimidazole
406. 5-Methoxy-2-{[[3,5-dimethyl -4-(2-(4-chlorphenyl)ethylthio)-2-pyridi- nyljmethyl jthio}-lH-benzimidazol406. 5-Methoxy-2 - {[[3,5-dimethyl -4- (2- (4-chlorophenyl) ethylthio) -2-pyridynyljmethyl jthio} -lH-benzimidazole
407. 5-Methoxy-2-{[[3,5-dimethyl-4-(5-(4-chlorphenyl)pentylthio)-2-pyridi- nyl jme-thyl ]thio}-lH-benzimidazol407. 5-Methoxy-2 - {[[3,5-dimethyl-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinyl nimethyl] thio} -IH-benzimidazole
408. 5-Methoxy-2-{[[3,5-dimethyl-4-(4-(4-chlorphenyl)butylthio)-2-pyridi- nyljmethyl]thio}-lH-benzimidazol408. 5-Methoxy-2 - {[[3,5-dimethyl-4- (4- (4-chlorophenyl) butylthio) -2-pyridinylylmethyl] thio} -lH-benzimidazole
409. 5-Methoxy-2-{[[3-methoxy-4-(3-(4-chlorphenyl)propylthio)-2-pyridinyl]- methyl jthio}-lH-benzimidazol409. 5-Methoxy-2 - {[[3-methoxy-4- (3- (4-chlorophenyl) propylthio) -2-pyridinyl] methyl jthio} -IH-benzimidazole
410. 5-Methoxy-2-{[[3-methoxy-4-(2-(4-chlorphenyl)ethylthio)-2-pyridinylj- ethyl ]thio)-lH-benzimidazol410. 5-Methoxy-2 - {[[3-methoxy-4- (2- (4-chlorophenyl) ethylthio) -2-pyridinylj-ethyl] thio) -IH-benzimidazole
411. 5-Methoxy-2-{[[3-methoxy-4-(5-(4-chlorphenyl)pentylthio)-2-pyridinylj- methyl]thio}-lH-benzimidazol411. 5-Methoxy-2 - {[[3-methoxy-4- (5- (4-chlorophenyl) pentylthio) -2-pyridinylj-methyl] thio} -lH-benzimidazole
412. 5-Methoxy-2-{[[3-methoxy-4-(4-(4-chlorphenyl)butylthio)-2-pyridinyl]- methyl ]thio}-lH-benzimidazol und ihre Salze.412. 5-Methoxy-2 - {[[3-methoxy-4- (4- (4-chlorophenyl) butylthio) -2-pyridinyl] methyl] thio} -lH-benzimidazole and its salts.
Gegenstand der Erfindung sind innerhalb der Ausgestaltung e solche neuenThe subject of the invention is such new ones within the configuration e
Verbindungen der Formel I, worinCompounds of formula I, wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet, einer der Substituenten R4 und R6 l-4C-Alkoxy und der andere Wasserstoff oder 1-4C-A1kyl bedeutet,R3 is hydrogen, one of the substituents R4 and R6 is 1-4C-alkoxy and the other is hydrogen or 1-4C-alkyl,
R5 3-7C-Cycloalkyl, 3-7C-Alkenyl , Aryl oder Arylmethyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro, Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet, und
n die Zahl 0 oder 1 bedeutet, und ihre Salze.R5 is 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, Nitro, trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen, and n represents the number 0 or 1, and their salts.
Gegenstand der Erfindung sind innerhalb der Ausgestaltung e weiterhin die folgenden neuen Verbindungen:The invention also relates to the following new compounds within embodiment e:
413. 2-[[(4-Benzylthio-3-methoxy-2-pyridinyl)methyl]thio]-lH-benzimidazol , Schmp. 151-153'C.413. 2 - [[(4-Benzylthio-3-methoxy-2-pyridinyl) methyl] thio] -IH-benzimidazole, m.p. 151-153'C.
414. 2-{[(4-Benzylthio-3-ethoxy-2-pyridinyl)methyljthio}-lH-benzimidazol414. 2 - {[(4-benzylthio-3-ethoxy-2-pyridinyl) methyljthio} -IH-benzimidazole
415. 2-{[(4-Butylthio-3-methoxy-2-pyridinyl)methyl]thio}-lH-benzimidazol415. 2 - {[(4-butylthio-3-methoxy-2-pyridinyl) methyl] thio} -IH-benzimidazole
416. 2-{[[4-(4-Chlorbenzylthio)-3-methoxy-2-pyridinyljmethyl]thio}-lH-benz- imidazol416. 2 - {[[4- (4-chlorobenzylthio) -3-methoxy-2-pyridinyljmethyl] thio} -lH-benzimidazole
417. 2-{[[4-(4-Methoxybenzylthio)-3-methoxy-2-pyridinyljmethyljthio}-1H- benzi idazol417. 2 - {[[4- (4-methoxybenzylthio) -3-methoxy-2-pyridinyljmethyljthio} -1H-benzide idazole
418. 2-{[[4-(4-Fluorbenzylthio)-3-methoxy-2-pyridinyljmethyl]thio}-lH-benz- i idazol418. 2 - {[[4- (4-fluorobenzylthio) -3-methoxy-2-pyridinyljmethyl] thio} -lH-benz-i idazole
419. 2-{[[4-(4-Methylbenzylthio)-3-methoxy-2-pyridinyljmethyl]thio}-lH- benzimidazol419. 2 - {[[4- (4-Methylbenzylthio) -3-methoxy-2-pyridinyljmethyl] thio} -IH-benzimidazole
420. 2-{[[4-(2-Fluorbenzylthio)-3-methoxy-2-pyridinyljmethyljthio}-lH-benz- imidazol420. 2 - {[[4- (2-fluorobenzylthio) -3-methoxy-2-pyridinyljmethyljthio} -lH-benzimidazole
421. 2-{[(4-Benzylthio-3-methoxy-2-pyridinyl)methyljthio}-5-methoxy-lH- benzimidazol421. 2 - {[(4-Benzylthio-3-methoxy-2-pyridinyl) methyljthio} -5-methoxy-1H-benzimidazole
422. 2-{[(4-Isopropylthio-3-methoxy-2-pyridinyl)methyl]thio}-lH-benzimida- zol422. 2 - {[(4-isopropylthio-3-methoxy-2-pyridinyl) methyl] thio} -lH-benzimidazole
423. 2-{[(3-Methoxy-4-propylthio-2-pyridinyl)methyl]thio}-lH-benzimidazol423. 2 - {[(3-methoxy-4-propylthio-2-pyridinyl) methyl] thio} -IH-benzimidazole
424. 2-{[(3-Methoxy-4-pentylthio-2-pyridinyl)methyl]thio}-lH-benzimidazol424. 2 - {[(3-methoxy-4-pentylthio-2-pyridinyl) methyl] thio} -lH-benzimidazole
425. 2-{[(4-Cyclopentylthio-3-methoxy-2-pyridinyl)methy1]thio}-lH-benzimi- dazol425. 2 - {[(4-Cyclopentylthio-3-methoxy-2-pyridinyl) methy1] thio} -IH-benzimizazole
426. 2-{[(4-Cyclopropylthio-3-methoxy-2-pyridinyl)methyl]thio}-lH-benzimi- dazol426. 2 - {[(4-Cyclopropylthio-3-methoxy-2-pyridinyl) methyl] thio} -lH-benzimizazole
427. 2-{[(4-Cyclohexylthio-3-methoxy-2-pyridinyl)methyl]thio}-lH-benzimida- zol427. 2 - {[(4-Cyclohexylthio-3-methoxy-2-pyridinyl) methyl] thio} -lH-benzimidazole
428. 2-{[(4-Allylthio-3-methoxy-2-pyridinyl)methyl]thio}-lH-benzimidazol428. 2 - {[(4-allylthio-3-methoxy-2-pyridinyl) methyl] thio} -lH-benzimidazole
429. 2-{[(3-Methoxy-4-(2-methyl-allylthio)-2-pyridinyl)methyljthio}-lH- benzimidazol429. 2 - {[(3-methoxy-4- (2-methyl-allylthio) -2-pyridinyl) methyljthio} -IH-benzimidazole
430. 2-{[(4-Benzylthio-3-methoxy-2-pyridinyl)methyljthio}-5-trifluormethyl- lH-benzimidazol
431. 2-{[(4-Butylthio-3-methoxy-2-pyridinyl)methyljthio}-5-trifluormethyl- lH-benzimidazol430. 2 - {[(4-Benzylthio-3-methoxy-2-pyridinyl) methyljthio} -5-trifluoromethyl-1H-benzimidazole 431. 2 - {[(4-butylthio-3-methoxy-2-pyridinyl) methyljthio} -5-trifluoromethyl-1H-benzimidazole
432. 2-{[[4-(4-Chlorbenzylthio)-3-methoxy-2-pyridinyljmethyljthio}-5-tri- fluormethyl-lH-benzimidazol432. 2 - {[[4- (4-chlorobenzylthio) -3-methoxy-2-pyridinyljmethyljthio} -5-trifluoromethyl-1H-benzimidazole
433. 2-{[[4-(4-Methoxybenzylthio)-3-methoxy-2-pyridinyljmethyljthio}-5-tri- fluormethyl-lH-benzimidazol433. 2 - {[[4- (4-Methoxybenzylthio) -3-methoxy-2-pyridinyljmethyljthio} -5-trifluoromethyl-1H-benzimidazole
434. 2-{[[4-(4-Fluorbenzylthio)-3-methoxy-2-pyridinyljmethyl]thio}-5-tri- fluormethyl-lH-benzimidazol434. 2 - {[[4- (4-fluorobenzylthio) -3-methoxy-2-pyridinyljmethyl] thio} -5-trifluoromethyl-1H-benzimidazole
435. 2-{[[4-(4-Methylbenzylthio)-3-methoxy-2-pyridinyljmethyljthio}-5-tri- fluormethyl-lH-benzimidazol435. 2 - {[[4- (4-Methylbenzylthio) -3-methoxy-2-pyridinyljmethyljthio} -5-trifluoromethyl-1H-benzimidazole
436. 2-{[[4-(2-Fluorbenzylthio)-3-methoxy-2-pyridinyljmethyljthio}-5-tri- fluormethyl-lH-benzimidazol und ihre Salze.436. 2 - {[[4- (2-fluorobenzylthio) -3-methoxy-2-pyridinyljmethyljthio} -5-trifluoromethyl-1H-benzimidazole and its salts.
Gegenstand der Erfindung sind innerhalb der Ausgestaltung f solche neuen Verbindungen der Formel I, worin Rl, R2 und R3 die für die neuen Verbindungen der Ausgestaltung c und R4, R5, R6 und n die für die neuen Verbindungen der Ausgestaltung d angegebenen Bedeutungen haben, und ihre Salze. Gegenstand der Erfindung innerhalb der Ausgestaltung f ist beispielsweise die folgende Verbindung:The invention relates, within embodiment f, to such new compounds of the formula I, in which R1, R2 and R3 have the meanings given for the new compounds of embodiment c and R4, R5, R6 and n have the meanings given for the new compounds of embodiment d, and their salts. The subject of the invention within the embodiment f is, for example, the following connection:
437. 5-Difluormethoxy-2-{[[3-methoxy-4-(2-phenylethylthio)-2-pyridinyljme¬ thyl]thio}-lH-benzimidazol-dihydrochlorid, Schmp. 148-150βC (Zers.).437. 5-difluoromethoxy-2 - {[[3-methoxy-4- (2-phenylethylthio) -2-pyridinyljme¬ ethyl] thio} -lH-benzimidazole dihydrochloride, mp. 148-150 β C (dec.).
Von den Verbindungen der Formel I sind solche bevorzugt, worin n die Zahl 0 bedeutet.Of the compounds of the formula I, preference is given to those in which n is the number 0.
Von den Verbindungen der Formel I sind weiterhin solche bevorzugt, worin Rl, R2 und R3 Wasserstoff bedeuten.Of the compounds of the formula I, preference is furthermore given to those in which R1, R2 and R3 are hydrogen.
Gegenstand der Erfindung ist auch ein Verfahren zur Herstellung der neuen Verbindungen der Formel I. Das Verfahren ist dadurch gekennzeichnet, daß man entsprechend substituierte, zu den im Europäischen Patent Nr. 150 586 analoge Ausgangsverbindungen in an sich bekannter Weise umsetzt.The invention also relates to a process for the preparation of the new compounds of the formula I. The process is characterized in that appropriately substituted starting compounds analogous to those in European Patent No. 150 586 are reacted in a manner known per se.
Die benötigten Ausgangsverbindungen sind bekannt oder sie können auf be¬ kannte Weise hergestellt werden.
Biologische UntersuchungenThe required starting compounds are known or they can be prepared in a known manner. Biological studies
Die Verbindungen der Formel I wurden bezüglich ihrer Wirksamkeit gegenüber Helicobacter pylori in Anlehnung an die von Tomoyuki Iwahi et al . (Antimi- crobial Agents and Chemotherapy, 1991, 490-496) beschriebene Methodik unter Verwendung von Columbia-agar (Oxoid) und bei einer Wachstumsperiode von 4 Tagen untersucht. Für die untersuchten Verbindungen ergaben sich hierbei die in der nachfolgenden Tabelle aufgeführten MIC-Werte (die angegebenen Nummern der Verbindungen stimmen mit den Verbindungsnummern in der Be¬ schreibung überein) .The compounds of the formula I were tested for their activity against Helicobacter pylori based on that of Tomoyuki Iwahi et al. (Antimicrobial Agents and Chemotherapy, 1991, 490-496) the methodology described using Columbia agar (Oxoid) and with a growth period of 4 days. The MIC values listed in the table below resulted for the compounds examined (the numbers of the connections given correspond to the connection numbers in the description).
Verbindung MIC-Wert
Connection MIC value
1 < 1,01 <1.0
3 ≤ 1,03 ≤ 1.0
4 < 1,04 <1.0
5 < 1,05 <1.0
6 < 1,06 <1.0
7 < 1,07 <1.0
42 < 1,042 <1.0
43 < 1,043 <1.0
105 < 1,0105 <1.0
106 < 1,0106 <1.0
107 < 1,0107 <1.0
108 < 1,0108 <1.0
109 < 1,0109 <1.0
129 < 1,0129 <1.0
413 < 1,0
413 <1.0
Claims
1. Verwendung von Verbindungen der Formel I,1. Use of compounds of the formula I,
worin wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor- methoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch¬ tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet, R3 Wasserstoff, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder ge¬ meinsam mit R2 gewünschtenfalls ganz oder teilweise durch Fluor substi¬ tuiertes l-2C-Alkylendioxy oder Chlortrifluorethylendioxy bedeutet, R4 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, R5 1-7C-Alkyl, 3-7C-Cycloalkyl , 3-7C-Alkenyl , Aryl oder Aryl-l-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substi¬ tuiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R1 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly substituted by fluorine, 1-4C-alkoxy, chlorodifluoromethoxy , 2-chloro-l, l, 2-trifluoroethoxy or together with R3, if desired, completely or partly by fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy, R3 is hydrogen, completely or predominantly fluorine-substituted 1-4C-alkoxy , Chlorodifluoromethoxy, 2-chloro-l, l, 2-trifluoroethoxy or together with R2, if desired, completely or partially substituted by fluorine-substituted 1-2C-alkylenedioxy or chlorotrifluoroethylene-dioxy, R4 is hydrogen, 1-4C-alkyl or 1-4C Alkoxy means R5 means 1-7C-alkyl, 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or aryl-1-7C-alkyl, where aryl stands for phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.R6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, and n is the number 0 or 1, and their pharmacologically acceptable salts for the production of medicaments for combating Helicobacter bacteria.
2. Verwendung von Verbindungen der Formel I nach Anspruch 1 und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arzneimitteln für die Bekämpfung von Helicobacter-Bakterien, wobei die Verbindungen der Formel I und ihre pharmakologisch verträglichen Salze ausgeschlossen sind, in denen2. Use of compounds of formula I according to claim 1 and their pharmacologically tolerable salts for the manufacture of medicaments for combating Helicobacter bacteria, the compounds of formula I and their pharmacologically tolerable salts being excluded, in which
Rl Wasserstoff,R1 hydrogen,
R2 Wasserstoff, Methyl, Methoxy oder Trifluormethyl,R2 is hydrogen, methyl, methoxy or trifluoromethyl,
R3 Wasserstoff,R3 is hydrogen,
R4 Wasserstoff oder 1-4C-Alkyl,R4 is hydrogen or 1-4C-alkyl,
R5 1-4C-Alkyl, 3-7C-Cycloalkyl , 3-4C-Alkenyl , Aryl oder Arylmethyl bedeu¬ tet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro oderR5 is 1-4C-alkyl, 3-7C-cycloalkyl, 3-4C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-A1kyl, Hydroxy, 1-4C-alkoxy, halogen, nitro or
Trifluormethyl und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl and R52 denotes hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff oder 1-4C-Alkyl und n die Zahl 0 oder 1 bedeutet.R6 is hydrogen or 1-4C-alkyl and n is the number 0 or 1.
3. Verwendung von Verbindungen der Formel I nach Anspruch 1, worin Rl Wasserstoff bedeutet,3. Use of compounds of formula I according to claim 1, wherein Rl is hydrogen,
R2 Wasserstoff, Methyl, Methoxy oder Trifluormethyl bedeutet,R2 represents hydrogen, methyl, methoxy or trifluoromethyl,
R3 Wasserstoff bedeutet,R3 means hydrogen,
R4 Wasserstoff oder 1-4C-A1kyl bedeutet,R4 denotes hydrogen or 1-4C-A1kyl,
R5 1-4C-Alkyl, 3-7C-Cycloalkyl , 3-4C-Alkenyl , Aryl oder Arylmethyl bedeu¬ tet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro oderR5 is 1-4C-alkyl, 3-7C-cycloalkyl, 3-4C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, Hydroxy, 1-4C-alkoxy, halogen, nitro or
Trifluormethyl und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl and R52 denotes hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff oder 1-4C-A1kyl bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien. R6 is hydrogen or 1-4C-alkyl, and n is the number 0 or 1, and their pharmacologically acceptable salts for the preparation of medicaments for the control of Helicobacter bacteria.
4. Verwendung von Verbindungen der Formel I nach Anspruch 1, worin Rl Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet,4. Use of compounds of the formula I according to claim 1, in which Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor- methoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch¬ tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet,R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly fluorine-substituted 1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R3 if desired, completely or partially means fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy,
R3 ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordi- fluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R2 ge¬ wünschtenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-A1- kylendioxy oder Chlortrifluorethylendioxy bedeutet,R3 completely or predominantly substituted by fluorine-1C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1, 2-trifluoroethoxy or together with R2, if desired, completely or partially by fluorine-substituted 1-2C-A1-kylenedioxy or chlorotrifluoroethylenedioxy means
R4 Wasserstoff oder 1-4C-A1kyl bedeutet,R4 denotes hydrogen or 1-4C-A1kyl,
R5 1-7C-Alkyl, 3-7C-Cycloalkyl , 3-7C-Alkenyl , Aryl oder Arylmethyl bedeu¬ tet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 means 1-7C-alkyl, 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, Hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff oder 1-4C-A1kyl bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.R6 is hydrogen or 1-4C-alkyl, and n is the number 0 or 1, and their pharmacologically acceptable salts for the preparation of medicaments for the control of Helicobacter bacteria.
5. Verwendung von Verbindungen der Formel I nach Anspruch 1, worin Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,5. Use of compounds of the formula I according to claim 1, in which Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet,R3 means hydrogen,
R4 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,R4 denotes hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 Aryl-2-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 is aryl-2-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet, R6 Wasserstoff, 1 -4C-Al kyl oder l -4C-Al koxy bedeutet und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen, R6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy and n is the number 0 or 1, and their pharmacologically acceptable salts for the preparation of medicaments for combating Helicobacter bacteria.
6. Verwendung von Verbindungen der Formel I nach Anspruch 1, worin6. Use of compounds of formula I according to claim 1, wherein
Rl Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet,R1 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet, einer der Substituenten R4 und R6 l-4C-Alkoxy und der andere Wasserstoff oder 1-4C-A1kyl bedeutet,R3 is hydrogen, one of the substituents R4 and R6 is 1-4C-alkoxy and the other is hydrogen or 1-4C-alkyl,
R5 1-7C-A1kyl , 3-7C-Cycloalkyl , 3-7C-Alkenyl , Aryl oder Arylmethyl bedeu¬ tet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 denotes 1-7C-A1kyl, 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-A1kyl, Hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy oder Halogen bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihren pharmakologisch verträglichen Salzen zur Herstellung von Arznei¬ mitteln für die Bekämpfung von Helicobacter-Bakterien.Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen, and n is the number 0 or 1, and their pharmacologically acceptable salts for the preparation of medicaments for combating Helicobacter bacteria.
7. Verbindungen der Formel I,7. Compounds of the formula I
(I)(I)
worin wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor¬ methoxy, 2-Chlor-1,1,2-trifluorethoxy oder gemeinsam mit R3 gewünsch¬ tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet,R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly substituted by fluorine-1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1,1,2-trifluoroethoxy or together with R3 if desired, completely or partially means fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy,
R3 Wasserstoff, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder ge¬ meinsam mit R2 gewünschtenfalls ganz oder teilweise durch Fluor substi¬ tuiertes 1-2C-AIkylendioxy oder Chlortrifluorethylendioxy bedeutet,R3 is hydrogen, completely or predominantly substituted by fluorine-1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R2, if desired, completely or partially substituted by fluorine-substituted 1-2C-alkylenedioxy or chlorotrifluoroethylene dioxy means
R4 Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet,R4 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 Aryl-4-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 is aryl-4-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihre Salze.R6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, and n is 0 or 1, and their salts.
8. Verbindungen der Formel I nach Anspruch 7, worin Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, R2 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor¬ methoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch¬ tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet, R3 Wasserstoff, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder ge¬ meinsam mit R2 gewünschtenfalls ganz oder teilweise durch Fluor substi¬ tuiertes l-2C-Alkylendioxy oder Chlortrifluorethylendioxy bedeutet, R4 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet, R5 3-7C-Cycloalkyl, 3-7C-Alkenyl , Aryl oder Aryl-l-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei8. Compounds of formula I according to claim 7, wherein Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly by Fluorine-substituted 1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, 1,2-trifluoroethoxy or together with R3, if desired, completely or partially substituted by fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy, R3 is hydrogen, 1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-1, l, 2-trifluoroethoxy, wholly or predominantly substituted by fluorine, or together with R2, if desired, completely or partially substituted by fluorine-substituted 1-2C-alkylenedioxy or chlorotrifluoroethylene dioxy, R4 Is hydrogen, 1-4C-alkyl or 1-4C-alkoxy, R5 is 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or aryl-1-7C-alkyl, where aryl is phenyl, which is substituted by R51 and R52 is substituted and in which
R51 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro, Trifluormethyl oder Trif1uormethoxy undR51 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro, trifluoromethyl or trifluoromethoxy and
R52 Wasserstoff, 1-4C-A1 yl , l-4C-Alkoxy oder Halogen bedeutet, R6 Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihre Salze, wobei die Verbindungen der Formel I und ihre Salze ausgeschlossen sind, in denenR52 is hydrogen, 1-4C-A1 yl, 1-4C-alkoxy or halogen, R6 is hydrogen, 1-4C-A1kyl or 1-4C-alkoxy, and n is 0 or 1, and their salts, the Compounds of formula I and their salts are excluded in which
Rl Wasserstoff,R1 hydrogen,
R2 Wasserstoff, Methyl, Methoxy oder Trifluormethyl, R3 Wasserstoff,R2 is hydrogen, methyl, methoxy or trifluoromethyl, R3 is hydrogen,
R4 Wasserstoff oder 1-4C-A1kyl , R5 3-7C-Cycloalkyl , 3-7C-Alkenyl , Aryl oder Arylmethyl bedeutet, wobeiR4 is hydrogen or 1-4C-alkyl, R5 is 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where
Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobeiAryl represents phenyl which is substituted by R51 and R52 and wherein
R51 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro oder Trifluorme¬ thyl undR51 1-4C-A1kyl, hydroxy, 1-4C-alkoxy, halogen, nitro or trifluoromethyl and
R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet, R6 Wasserstoff oder 1-4C-A1kyl und n die Zahl 0 oder 1 bedeutet.R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen, R6 is hydrogen or 1-4C-alkyl and n is the number 0 or 1.
9. Verbindungen der Formel I nach Anspruch 7, worin9. Compounds of formula I according to claim 7, wherein
Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy, Halogen, Trifluormethyl, ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordifluor¬ methoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R3 gewünsch¬ tenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-Alkylen- dioxy oder Chlortrifluorethylendioxy bedeutet,R2 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen, trifluoromethyl, completely or predominantly fluorine-substituted 1-4C-alkoxy, chlorodifluoromethoxy, 2-chloro-l, 1,2-trifluoroethoxy or together with R3 if desired, completely or partially means fluorine-substituted 1-2C-alkylene-dioxy or chlorotrifluoroethylene-dioxy,
R3 ganz oder überwiegend durch Fluor substituiertes l-4C-Alkoxy, Chlordi¬ fluormethoxy, 2-Chlor-l,l,2-trifluorethoxy oder gemeinsam mit R2 ge¬ wünschtenfalls ganz oder teilweise durch Fluor substituiertes 1-2C-A1- kylendioxy oder Chlortrifluorethylendioxy bedeutet,R3 completely or predominantly substituted by fluorine-1C-alkoxy, chlorodi-fluoromethoxy, 2-chloro-1, 1, 2-trifluoroethoxy or together with R2, if desired, completely or partly by fluorine-substituted 1-2C-A1-kylenedioxy or chlorotrifluoroethylenedioxy means
R4 Wasserstoff oder 1-4C-Alkyl bedeutet,R4 represents hydrogen or 1-4C-alkyl,
R5 3-7C-Cycloalkyl, 3-7C-Alkenyl , Aryl oder Arylmethyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro, Trifluormethyl oder Trifluormethoxy undR5 is 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro, trifluoromethyl or trifluoromethoxy and
R52 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy oder Halogen bedeutet, R6 Wasserstoff oder 1-4C-A1kyl bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihre Salze.R52 is hydrogen, 1-4C-A1kyl, 1-4C-alkoxy or halogen, R6 is hydrogen or 1-4C-A1kyl, and n is 0 or 1, and their salts.
10. Verbindungen der Formel I nach Anspruch 7, worin Rl Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet,10. Compounds of formula I according to claim 7, wherein Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet,R3 means hydrogen,
R4 Wasserstoff, 1-4C-A1kyl oder l-4C-Alkoxy bedeutet,R4 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 Aryl-4-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 Wasserstoff, 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro,R5 is aryl-4-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is hydrogen, 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro,
Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy oder Halogen bedeutet,Trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet und n die Zahl 0 oder 1 bedeutet, und ihre Salze.R6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy and n is the number 0 or 1, and their salts.
11. Verbindungen der Formel I nach Anspruch 7, worin Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,11. Compounds of formula I according to claim 7, wherein Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet,R3 means hydrogen,
R4 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,R4 denotes hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R5 Aryl-2-7C-alkyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 1-4C-A1kyl , Hydroxy, l-4C-Alkoxy, Halogen, Nitro, Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy oder Halogen bedeutet,R5 is aryl-2-7C-alkyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, nitro, trifluoromethyl or trifluoromethoxy and R52 is hydrogen Is 1-4C-alkyl, 1-4C-alkoxy or halogen,
R6 Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet und n die Zahl 0 oder 1 bedeutet, und ihre Salze.R6 is hydrogen, 1-4C-alkyl or 1-4C-alkoxy and n represents the number 0 or 1, and their salts.
12. Verbindungen der Formel I nach Anspruch 7, worin Rl Wasserstoff, 1-4C-Alkyl oder l-4C-Alkoxy bedeutet,12. Compounds of formula I according to claim 7, wherein Rl is hydrogen, 1-4C-alkyl or 1-4C-alkoxy,
R2 Wasserstoff, 1-4C-A1kyl , l-4C-Alkoxy, Halogen oder Trifluormethyl be¬ deutet,R2 means hydrogen, 1-4C-alkyl, 1-4C-alkoxy, halogen or trifluoromethyl,
R3 Wasserstoff bedeutet, einer der Substituenten R4 und R6 l-4C-Alkoxy und der andere Wasserstoff oder 1-4C-A1kyl bedeutet,R3 is hydrogen, one of the substituents R4 and R6 is 1-4C-alkoxy and the other is hydrogen or 1-4C-alkyl,
R5 3-7C-Cycloalkyl, 3-7C-Alkenyl , Aryl oder Arylmethyl bedeutet, wobei Aryl für Phenyl steht, das durch R51 und R52 substituiert ist und wobei R51 1-4C-Alkyl, Hydroxy, l-4C-Alkoxy, Halogen, Nitro, Trifluormethyl oder Trifluormethoxy und R52 Wasserstoff, 1-4C-Alkyl, l-4C-Alkoxy oder Halogen bedeutet, und n die Zahl 0 oder 1 bedeutet, und ihre Salze.R5 is 3-7C-cycloalkyl, 3-7C-alkenyl, aryl or arylmethyl, where aryl is phenyl which is substituted by R51 and R52 and where R51 is 1-4C-alkyl, hydroxy, 1-4C-alkoxy, halogen, Nitro, trifluoromethyl or trifluoromethoxy and R52 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy or halogen, and n is 0 or 1, and their salts.
13. Verwendung gemäß Anspruch 1 von Verbindungen der Formel I nach Anspruch 1, worin n die Zahl 0 bedeutet.13. Use according to claim 1 of compounds of formula I according to claim 1, wherein n is the number 0.
14. Verwendung gemäß Anspruch 1 von Verbindungen der Formel I nach Anspruch 1, worin n die Zahl 0 bedeutet und Rl, R2 und R3 Wasserstoff bedeuten.14. Use according to claim 1 of compounds of formula I according to claim 1, wherein n is the number 0 and Rl, R2 and R3 are hydrogen.
15. Verbindungen der Formel I nach Anspruch 7, worin n die Zahl 0 bedeutet.15. Compounds of formula I according to claim 7, wherein n is the number 0.
16. Verbindungen der Formel I nach Anspruch 7, worin n die Zahl 0 bedeutet und Rl, R2 und R3 Wasserstoff bedeuten.16. Compounds of formula I according to claim 7, wherein n is the number 0 and Rl, R2 and R3 are hydrogen.
17. Anwendung von Verbindungen nach Anspruch 7 bei der Bekämpfung von Heli¬ cobacter-Bakterien.17. Use of compounds according to claim 7 in the control of Heli¬ cobacter bacteria.
18. Arzneimittel zur Bekämpfung von Helicobacter-Bakterien enthaltend eine Verbindung nach Anspruch 7 und/oder ihr pharmakologisch verträgliches Salz. 18. Medicament for combating Helicobacter bacteria containing a compound according to claim 7 and / or its pharmacologically acceptable salt.
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH3780/92 | 1992-12-10 | ||
| CH3781/92 | 1992-12-10 | ||
| CH378192 | 1992-12-10 | ||
| CH378092 | 1992-12-10 | ||
| CH378292 | 1992-12-10 | ||
| CH3779/92 | 1992-12-10 | ||
| CH377892 | 1992-12-10 | ||
| CH3782/92 | 1992-12-10 | ||
| CH3778/92 | 1992-12-10 | ||
| CH377992 | 1992-12-10 | ||
| PCT/EP1993/003503 WO1994013290A1 (en) | 1992-12-10 | 1993-12-10 | Use of alkylthiopyridines for controlling helicobacter bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0673246A1 true EP0673246A1 (en) | 1995-09-27 |
Family
ID=27509157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP94902761A Withdrawn EP0673246A1 (en) | 1992-12-10 | 1993-12-10 | Use of alkylthiopyridines for controlling helicobacter bacteria |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0673246A1 (en) |
| AU (1) | AU5699594A (en) |
| WO (1) | WO1994013290A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5504082A (en) * | 1992-06-01 | 1996-04-02 | Yoshitomi Pharmaceutical Industries, Ltd. | Pyridine compound and pharmaceutical compostions |
| CN1070192C (en) * | 1994-06-10 | 2001-08-29 | 比克·古尔顿·劳姆贝尔格化学公司 | Thipyridines for use in control of helicobacter bacteria |
| SK281683B6 (en) * | 1994-07-20 | 2001-06-11 | Byk Gulden Lomberg Chemische Fabrik Gmbh | THIOPYRIDYL COMPOUNDS AND THEIR USE |
| RU2449805C1 (en) | 2011-01-27 | 2012-05-10 | Общество С Ограниченной Ответственностью "Гармония" | Peptide pharmaceutical composition, based drug for gastroduodenal diseases caused by helicobacter pylori, and method of using it |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4575554A (en) * | 1983-12-05 | 1986-03-11 | The Upjohn Company | Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents |
| KR900701270A (en) * | 1988-08-23 | 1990-12-01 | 안데르스 베딘 | Treatment of glaucoma and related disorders in human eyes with pyridinylmethyl (sulfinyl or thio) benzimidazole |
| JP2694361B2 (en) * | 1989-02-09 | 1997-12-24 | アストラ アクチエボラグ | Antibacterial agent |
| DE69014141T2 (en) * | 1989-02-10 | 1995-05-24 | Takeda Chemical Industries Ltd | Use of benzimidazole derivatives as antibacterial agents. |
| GB9018603D0 (en) * | 1990-08-24 | 1990-10-10 | Smith Kline French Lab | Compositions |
| EP0567643A4 (en) * | 1991-01-16 | 1995-07-19 | Yoshitomi Pharmaceutical | NEW PYRIDE DERIVATIVE AND ITS USE AS A SELECTIVE MEDICINAL PRODUCT. |
-
1993
- 1993-12-10 AU AU56995/94A patent/AU5699594A/en not_active Abandoned
- 1993-12-10 WO PCT/EP1993/003503 patent/WO1994013290A1/en not_active Ceased
- 1993-12-10 EP EP94902761A patent/EP0673246A1/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9413290A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5699594A (en) | 1994-07-04 |
| WO1994013290A1 (en) | 1994-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3752201T2 (en) | Pyridine derivatives, their pharmaceutical compositions, their use in the manufacture of medicinal products with therapeutic or preventive value and processes for their manufacture | |
| DE2037610C3 (en) | ||
| DE3783356T2 (en) | BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME. | |
| TWI269795B (en) | Potassium salt of (S)-omeprazole | |
| EP2385942A1 (en) | Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases | |
| DE60022227T2 (en) | 2- (1H-INDOL-3-YL) -2-OXO-ACETAMIDE WITH ANTITUMORAL EFFECT | |
| DE3855549T2 (en) | Benzimidazole derivatives and therapeutic anti-ulcer agents containing them | |
| EP1226143A2 (en) | Imidazopyridine derivatives used as phosphodiesterase vii inhibitors | |
| DE2454632A1 (en) | NEW 5(6)-SUBSTITUTED BENZIMIDAZOLE-2-CARBAMATS AND THEIR PRODUCTION | |
| DE19513048C2 (en) | New 5-pyrrolyl-6-halogen-2-pyridylmethylsulfinylbenzimidazole derivatives | |
| EP0524974A1 (en) | Pyridines as medicaments | |
| DE2742509A1 (en) | PIPERAZINYLPYRIDINE, THE PROCESS FOR THEIR MANUFACTURING AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| DE60314105T2 (en) | ALKYLAMONIUM SALT OF OMEPRAZOL AND ESOMEPRAZOLE | |
| EP0673246A1 (en) | Use of alkylthiopyridines for controlling helicobacter bacteria | |
| DE3716131A1 (en) | SUBSTITUTED 2-ACYLPYRIDINE (ALPHA) - (N) -HETARYLHYDRAZONE AND THESE MEDICINAL PRODUCTS | |
| EP0180115A2 (en) | 1,2,4-Triazolyl carbamates and their acid addition salts, process for their preparation and medicines | |
| EP0548103A1 (en) | Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria | |
| EP0198208A1 (en) | Substituted benzimidazole derivatives, process for their preparation, pharmaceutical compositions containing them and their use as inhibitors of gastric-acid secretion | |
| DE19915365A1 (en) | Tetrahydropyridazine derivatives | |
| EP0695303B1 (en) | Pyridinium salts and their use for controlling helicobacter bacteria | |
| EP0706523B1 (en) | Substituted arylthioalkylthiopyridines | |
| EP0683776B1 (en) | Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria | |
| DE60304596T2 (en) | IN 3-POSITION HETEROCYCLICALLY SUBSTITUTED PYRIDOINDOLON DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
| DE68902152T2 (en) | PYRIMIDINE DERIVATIVES WITH ANTI-ULCUS EFFECT. | |
| DE3917232A1 (en) | New N-aryl:methyl 4-amino-quinoline derivs - useful as gastrointestinal medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19950608 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 19951123 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19970715 |